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1 Introduction 
1.1 Hallmarks of cancer and chemotherapy resistance 
Tumorigenesis is a multistep process during which genetic alterations occur 
that could drive to a progressive transformation of normal human cells into 
highly malignant cells. There are different types of cancer in human 
population and they mostly have an age dependent incidence (Renan 1993). 
Most of the cancers could be characterized by six essential alterations in cell 
physiology that correlate in malignant tumor growth. These alterations are 
listed in Fig. 1 (Hanahan and Weinberg 2000).  
 
Fig. 1 Acquired capabilities of cancer (adapted from (Hanahan and Weinberg 
2000)). The tumor cells are characterized by their uncontrolled proliferative potential 
and their ability to invade tissues and to metastasize. Cancer cells have developed 
specific molecular mechanisms in order to avoid growth inhibition and apoptosis. In 
addition, they stimulate their own growth by auto- and paracrine signals and the 
induction of angiogenesis. 
 
Tumor cells are able to use their own signals and behave independently from 
their normal tissue microenvironment. The overexpression of specific 
receptors could lead to a high response of cancer cells to the environmental 
levels of growth factors (GF) that under normal conditions would not lead to 
proliferation (Hanahan and Weinberg 2000). In addition cancer cells are using 
for their survival the PI3 kinase pathway as a downstream factors (Downward 
1998). PI3 kinase pathway normally regulates cellular processes such as cell 
growth, survival, differentiation, chemotaxis and metabolism (Workman, 
Clarke et al. 2006). Loss of PTEN phosphatase as well as overexpression of 
the upstream receptor of tyrosine kinases and downstream serine/threonine 
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kinase PKB/Akt, are highly associated with tumorigenesis (Vivanco and 
Sawyers 2002). Therefore PI3 kinases inhibitors as well as drugs targeting 
other members of the pathway, for example PKB/Akt would be pivotal to cure 
those tumors. Some of the known inhibitors are: LY294002 and wortmanin 
(Yaguchi, Fukui et al. 2006).      
Another characteristic of the tumor cells is the resistance toward apoptosis 
induction. The p53 tumor suppressor protein can control the apoptosis by 
upregulating pro-apoptotic protein Bax in response to DNA damage. Bax 
leads to the mitochondrial apoptotic pathway activation (Hanahan and 
Weinberg 2000). Loss via mutations of p53 is common in cancer cells and it is 
observed in 50% of human cancers, that result in the removal of the key 
regulator of apoptosis in response to DNA damage (Harris 1996) and leads to 
therapy resistance.      
1.2 Microenvironment of solid tumors 
Most of the solid tumors are characterized of regions of acute and chronic 
hypoxia or even anoxia that correspond to a poor clinical prognosis for the 
cancer patients (Fig. 2). Under normoxic conditions, ionizing radiation 
produces DNA damage such as DNA double strand breaks. Radio-
sensitization requires the presence of O2 at the time of ionizing radiation in 
order to make permanent and irreparable lethal DSBs produced by free 
radicals. Therefore, under hypoxic conditions the number of double strand 
breaks are 2-3 fold decreased (Frankenberg-Schwager, Frankenberg et al. 
1991; Brown, Evans et al. 1992; Wang, Biedermann et al. 1992; Terris, Ho et 
al. 2002; Olive and Banath 2004; Bristow and Hill 2008). Genetic instability 
that is caused by hypoxia can arise as a function to hypoxia-mediated 
resistance to apoptosis and decrease of DNA repair (Moulder and Rockwell 
1987; Li, Little et al. 2001; Harris 2002).  This contributes to the resistance of 
these hypoxic tumors to classical chemotherapy and radiotherapy. 
Hypoxia inducible factor HIF-1 plays a key role in response to cellular 
hypoxia. HIF-1 consists of two subunits, the oxygen sensitive HIF-1 and the 
constitutively expressed HIF-1 (Wang, Jiang et al. 1995). Under normoxic 
conditions, the von Hippel-Lindau tumor suppressor (pVHL), which is the 
recognition component of an E3 ubiquitin ligase complex targets HIF-
1 leading to its ubiquitylation and subsequent proteosomal degradation 
(Iwai, Yamanaka et al. 1999; Lisztwan, Imbert et al. 1999; Cockman, Masson 
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et al. 2000; Kamura, Sato et al. 2000; Ohh, Park et al. 2000; Tanimoto, 
Makino et al. 2000). Under hypoxic conditions, the proline hydroxylases 
cannot be active so that proline residues are not hydroxylated, resulting in an 
accumulation of HIF-1 . HIF-1 then translocates to the nucleus where it 
dimerises with the subunit HIF-1 HIF-1 recruits cofactors such as 
CBP/P300 for its full activation and translation of the target genes such as 
vascular endothelial growth factor (VEGF) (Forsythe, Jiang et al. 1996; 
Yamashita, Discher et al. 2001) (Fig.3).          
In cancer, both hypoxia and mutations in oncogenes and tumor suppressor 
genes increase HIF activity. HIF-1α was found to be highly expressed in solid 
tumors such as colon, breast, gastric, lung, skin, ovarian, pancreatic, prostate 
and renal carcinomas (Zhong, De Marzo et al. 1999). HIF-1 target genes 
have been identified, and many of these are associated with angiogenesis, 
invasion, and metastasis (Semenza 2003). Therefore high levels of HIF-1α 
expression correlate with poor prognosis in tumor therapy making it potential 
target for anticancer drug development. A number of drugs that inhibit HIF-1α 
have been redeveloped, however, none of them directly and specially target 
HIF-1 (Giaccia, Siim et al. 2003; Semenza 2003; Shalini and Bansal 2006).     
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Fig. 2 Solid tumor microenvironment. Solid tumors are characterized of regions 
with hypoxia and necrotic regions. Hypoxic cells are able to survive, however, they 
are protected from chemotherapy. Modified from (Kizaka-Kondoh, Kuchimaru et al. 
2011). 
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Fig. 3 HIF-1α regulation in oxygen dependent manner (Carroll and Ashcroft 
2005). In normoxia, HIF-1α is hydroxylated by proline hydroxylases (PHD1, 2 and 3) 
in the presence of O2, Fe
2+
, 2-oxoglutarate (2-OG) and ascorbate. Hydroxylated HIF-
1α is recognized by pVHL (the product of the von Hippel–Lindau tumour suppressor 
gene), which, together with an ubiquitin ligase, tags HIF-1α with polyubiquitin and 
allows the proteasome recognition and subsequent degradation. In response to 
hypoxia, proline hydroxylation is inhibited. VHL can no longer bind and target HIF-1α 
for proteasomal degradation. This leads to HIF-1α accumulation and translocation to 
the nucleus. There, HIF-1α dimerises with HIF-1β and binds to hypoxia-response 
elements (HREs) within the promoters of target genes and recruits transcriptional co-
activators such as p300/CBP for its full activation. 
 
1.3 Application of endoperoxides as promising anticancer drug 
Artemisinin (ART) is a natural compound extracted from the woormwood 
Artemisia annua L.; it is a sesquiterpen lactone containing an endoperoxide 
bridge which is essential for its activity. ART exerts an anti-malaria activity by 
generation of organic free radicals through cleavage of the endoperoxide 
bridge (Meshnick 2002). It has been reported that application of ART and its 
derivatives is associated with an absence of significant toxicity in patients at 
least when used in anti-malaria treatment (Park, O'Neill et al. 1998; Ribeiro 
and Olliaro 1998). Recent studies have identified that ART is also active 
against human cancer cells in vitro and in vivo (Beekman, Barentsen et al. 
1997; Beekman, Wierenga et al. 1998; Posner, Ploypradith et al. 1999; 
Efferth, Dunstan et al. 2001; Posner, Paik et al. 2003; Jeyadevan, Bray et al. 
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2004). The chemical structures of artemisinin and its derivative 
dihydroartemisinin are listed in Fig. 4.  
 
Fig. 4 Chemical structure of artemisinin and dihydroartemisinin (Hou, Wang et 
al. 2008) 
 
It is hypothesized, that ART reacts with Fe(ll) species to form toxic carbon-
centered radicals (O'Neill and Posner 2004) (Fig. 5). Iron is required for 
bioactivation of the endoperoxide bridge and is essential for the cytotoxicity of 
the drug (Beekman, Barentsen et al. 1997; Beekman, Wierenga et al. 1998). 
Interestingly, the cell lines which are the most sensitive to the drug, are 
characterized by high iron uptake, an effect that correlates with high 
proliferation of tumor cells (Kwok and Richardson 2002; Disbrow, Baege et al. 
2005). Endoperoxide mediated cytotoxicity in cancer cells proceeds via 
apoptosis induction in caspase dependent manner, although the exact 
molecular basis of this induction has not been explained yet (Li, Shan et al. 
2001; Sadava, Phillips et al. 2002; Wu, Zhou et al. 2004; Disbrow, Baege et 
al. 2005). Dihydroartemisinin has been reported to be an effective and water 
soluble analog (Janse, Waters et al. 1994; Tu 1999).  
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Fig. 5 Proposed mechanism of endoperoxides action (Mercer, Maggs et al. 
2007) Intracellular free iron plays a major role in the activation of ART 
endoperoxides. Endoperoxides induce concentration and time-dependent apoptosis 
via mitochondrial membrane depolarization, caspase activation, and DNA 
degradation.  
 
1.4 Mechanisms of death  
Although much is known about apoptosis, therapy-induced cell death has 
been reported to involve other death pathways as potential targets of therapy. 
Understanding the differences between the cell death pathway defects in 
each type of cancer, may offer a more tailored approach to choose specific 
and efficient treatments in order to enhance cell death (Speirs, Hwang et al. 
2011). Besides the classical death pathways such as apoptosis, cell death 
can be induced by necrosis, autophagy and cellular senescence. 
1.4.1 Apoptosis  
The induction of apoptosis originates by two alternative pathways: one is 
mediated by the so called death receptor “extrinsic pathway” and the other 
pathway critically involves the mitochondria and is known as “intrinsic 
pathway”. Both pathways specially lead to the activation of caspases as 
critical apoptosis effectors. Active caspases cleave cellular substrates, 
leading to morphological changes characteristic of apoptosis (Krammer 1999; 
Schmitz, Kirchhoff et al. 2000).  
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Death receptors family (CD95R, TRAIL – R1, TRAIL-R2), is activated by the 
binding of ligands such as CD95L, TRAIL (TNF related apoptosis-inducing 
ligand) and leads to the formation of the DISC (death-inducing signaling 
complex). That results in caspase-8 activation via recruitment of DISC by the 
FAS-associated death domain protein (FADD). Active caspase-8 cleaves the 
effector caspase – 3 either directly or indirectly via mitochondrial apoptosis 
pathway (Ashkenazi 2002).  
In the mitochondrial apoptosis pathway, downstream effector caspases are 
activated upon release into the cytosol of apoptogenic factors, such as 
cytochrome c, from the mitochondrial inner membrane space. Cytochrome c 
release triggers caspase-3 activation via formation of apoptosome (Apaf1, 
cytochrome-c and caspase 9) (Saelens, Festjens et al. 2004). Both pathways 
are represented in Fig. 6.  
 
 
Fig. 6 The two main apoptotic signaling pathways. During apoptosis signaling 
through death receptors pathway, death ligands such as CD95L bind to their 
receptors and lead to the formation of the death-inducing signaling complex (DISC).  
The initiator procaspase 8 is recruited to the DISC by FADD (FAS-associated death 
domain protein). Caspase 8 is activated by autocatalytic cleavage. Chemotherapy, 
irradiation and other stimuli can induce apoptosis via mitochondrial pathway. Bcl-2 
protein family plays essential role in this pathway. Pro-apoptotic proteins like BAX, 
BID, BAD and BIM are important mediators of apoptosis signals. Activation of the 
mitochondria leads to the cytochrome c release into the cytosol. Cytochome c binds 
APAF-1 (apoptotic protease activating factor 1) to form apoptosome. At the 
apoptosome, initiator caspase 9 is activated. Both intrinsic and extrinsic apoptotic 
pathways lead to activation to the downstream effector caspases and inactivation of 
PARP (Chinnaiyan, O'Rourke et al. 1995)    
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1.4.2 Bcl-2 protein family 
Bcl-2 proteins are essential in regulating death pathways at the mitochondrial 
level. Bcl-2 members can be divided into three subfamilies: the anti-apoptotic 
(Bcl-2, Bcl-XL, Bcl-w, Mcl-1), the pro-apoptotic multidomain such as Bax, Bak 
and Bok/Mtd and the pro-apoptotic BH3-only subfamily listed in Fig 7 (Huang 
and Strasser 2000; Puthalakath and Strasser 2002; Borner 2003). The 
survival proteins such as, Bcl-2 and Bcl-XL, share three to four conserved Bcl-
2 homology domains and are named “multidomain anti-apoptotic” members. 
The executioner proteins such as Bax and Bak share three conserved 
domains and are known as “multidomain pro-apoptotic” proteins. The “BH3-
only” members share only the BH3 domain and function as sensors of cellular 
stress (Cory and Adams 2002; Petros, Olejniczak et al. 2004).  
 
 
Fig. 7 BCL-2 family proteins are structurally defined by their BCL-2 homology 
domains (Walensky 2006). Bcl-2 proteins are subdivided either to pro- or anti-
apoptotic and could be further subdivided into three groups. The antiapoptotic Bcl-2 
subfamily proteins possess four short Bcl-2 homology (BH) domains and a C-terminal 
transmembrane (TM) domain. The pro-apoptotic multidomain such as Bax, Bak and 
Bok/Mtd are characterized by three BH domains and a hydrophobic TM domain. 
Finally the pro-apoptotic BH3-only subfamily, consist of only a BH3 domain. 
 
The network of interactions among Bcl-2 family members is complex and 
remains a focus of recent investigation. The ability of anti-apoptotic proteins 
to form heterodimers with multidomain pro-apoptotic proteins suggests that 
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neutralizing competition plays an important role in the suppression of cell 
death (Oltvai, Milliman et al. 1993; Sedlak, Oltvai et al. 1995; Diaz, Oltersdorf 
et al. 1997; Sattler, Liang et al. 1997; Gross, Jockel et al. 1998; Wang, Gross 
et al. 1998; Suzuki, Youle et al. 2000). 
1.4.3 Caspases 
Dependent from their function, structure and substrate specificity, human 
caspases are subdivided into three groups. Group-I or inflammatory 
caspases (caspase-1, -4, -5, -12) are characterized by the presence of a 
caspase recruitment domain (CARD) at the N-terminus and become activated 
by initiator caspases (Thornberry, Rano et al. 1997). Group-II, or effector 
caspases, (caspase-3, -6 and -7) are responsible for the cleavage of cellular 
components during apoptosis. Group-III, or initiator caspases (caspases-2, -
8, -9, -10) are characterized by the presence of protein-interacting domains in 
their N-terminus (Alenzi, Lotfy et al. 2010). Caspases are essential 
components during apoptosis. They function by cleaving cytoskeletal and 
nuclear proteins critical for maintenance of cell structure, and enzymes 
involved in metabolism and repair (Gorman, Orrenius et al. 1998). The 
caspases are synthesized as inactive pro-enzymes (zymogens) and, after 
appropriate apoptotic signaling, they are converted into mature enzymes by 
the formation of heterodimers that contain the active catalytic unit. Caspases 
with large prodomains are thought to be involved in the initiation of the 
apoptosis response and known as initiator caspases. Caspases with short 
prodomains are apparently activated by the initiator caspases and known as 
effector caspases (Fig. 8) (Nicholson and Thornberry 1997; Gupta 2000). 
Caspase-3 is the major effector caspase, which cleaves many of cellular 
substrates during apoptosis (Porter and Janicke 1999). Caspase-7 is highly 
similar to caspase-3 and demonstrates similar substrate specificity (Fuentes-
Prior and Salvesen 2004).  
The initiator caspases (usually caspase-8) cleave Bid, the link between the 
death receptor and the mitochondrial apoptosis pathway and leads to Bax 
activation and cytochrome c release (Liu, Zou et al. 1997) (Li, Zhu et al. 1998; 
Steemans, Goossens et al. 1998).  
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Fig. 8 Caspase structure (Riedl and Shi 2004). The caspase family. Three major 
groups of caspases are presented. Group I: apoptosis effector caspases, group II: 
apoptosis initiator caspases The CARD, the DED, and the large (p20) and small (p10) 
catalytic subunits are indicated.  
1.4.4 Necrosis 
Necrosis, is a non apoptotic form of cell death characterized by depletion of 
cellular ATP, plasma membrane rupture, cell swelling, and marked 
inflammation (Holler, Zaru et al. 2000; Xu, Tavernarakis et al. 2001; Baines, 
Kaiser et al. 2005; Nakagawa, Shimizu et al. 2005; Schinzel, Takeuchi et al. 
2005). It has been reported that many cell types that can not initiate or 
propagate the apoptotic signaling cascade do not survive, but die by necrosis 
which is also a regulated process (Fiers, Beyaert et al. 1999; Festjens, 
Vanden Berghe et al. 2006).  
Some pathophysiological processes, such as ischemia–reperfusion (I/R), 
inflammation, reactive oxygen species (ROS)-induced injury and glutamate 
excitotoxicity, induce necrotic cell death in vivo (Vanlangenakker, Vanden 
Berghe et al. 2008). Mitochondria-derived ROS are an absolute requirement 
in necrotic killing of L929 cells by TNF, and are also responsible for the 
ultrastructural changes in the mitochondria and endoplasmic reticulum (ER) 
during cell death (Schulze-Osthoff, Bakker et al. 1992).  Necrotic cell death is 
represented in Fig. 9. 
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Fig. 9 Hallmarks of the apoptotic and necrotic cell death process. (Van Cruchten 
and Van Den Broeck 2002). While the process of apoptosis is characterized by 
cellular condensation, necrotic cells are swelling, during necrosis the nuclear 
structure is maintained until the membrane bursts due to the swelling and 
subsequently the intracellular components are released and may lead to acute 
inflammatory responses.  
1.4.5 Autophagy 
Autophagy is a cellular catabolic degradation in response to cellular stress 
conditions or starvation of cells. During autophagy, organelles and cytoplasm 
are digested and recycled in order to maintain cellular metabolism and 
homeostasis (Levine and Klionsky 2004; Mizushima 2007). Autophagy is 
regulated by mTOR downstream of PI3 kinase/AKT, which regulates cell 
growth and protein synthesis. However, how exactly autophagy is  regulated 
requires further investigations (Mathew, Karantza-Wadsworth et al. 2007).   
Tumors resistant to apoptosis, need autophagy to survive metabolic stress 
(Degenhardt, Mathew et al. 2006; Karantza-Wadsworth, Patel et al. 2007; 
Karantza-Wadsworth and White 2007). On the other hand, autophagy has 
been considered also as type II programmed cell death (Edinger and 
Thompson 2003; Levine 2005). In addition it was reported, that treatment of 
apoptosis resistant cancer cells with cytotoxic drugs may induce caspase 
independent cell death by autophagy and that makes it important for further 
investigations (Shimizu, Kanaseki et al. 2004; Boya, Gonzalez-Polo et al. 
2005; Colell, Ricci et al. 2007; Karantza-Wadsworth, Patel et al. 2007).  
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An autophagosome marker is the protein LC3 which is cleaved during 
autophagy. LC3 cleavage involves conversion of the LC3-I isoform into LC3-II 
that correlates with the autophagosome formation. LC3-II is the only protein 
known that specifically associates with autophagosomes (Kabeya, Mizushima 
et al. 2000) (Fig. 10).  
Lysosome
Αutophagosome
LC3  
3MA
Breakdown 
and recycling
Autolysosome
Aggregated 
proteins
LC3 l LC3 ll
Formation
Fusion
Phagophore
Αutophagy
 
Fig. 10 Autophagy pathway. The distinct stages are controlled by atg gene 
products. The vesicle nucleation and vesicle elongation process in the initial stages of 
autophagy sequester the cytosolic contents and result in the formation of the 
autophagosome, a double-membrane vesicle. The outer membrane then fuses with 
the lysosomes to form the autolysosome and the internal content is depredated by 
lysosomal hydrolases.    
1.4.6 Senescence 
Cells which stop dividing become senescent  and lose the ability to proliferate 
(Pani ; Chang, Broude et al. 1999; Itahana, Campisi et al. 2007; Rodier, 
Coppe et al. 2009) The phenotype of senescent cells is characterized by 
large or flat morphology. Cellular senescence is a metabolically active form of 
irreversible growth arrest and it is regulated by tumor suppressor pathways 
like p53 and p16 INK4A/pRb (Fig.11).  This complicated cellular event is 
initiated in response to extracellular or intracellular stress (Davalos, Coppe et 
al. ; Campisi 2001; Wright and Shay 2001; Ben-Porath and Weinberg 2005) 
(Kulju and Lehman 1995; Narita, Nunez et al. 2003). This observation leads 
to the hypothesis that senescence may be used as a tumor suppressor 
mechanism (Collins and Sedivy 2003; Ohtani, Yamakoshi et al. 2004; Gil and 
Peters 2006).  
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Normal cells can also undergo replicative senescence which is associated 
with a shortening of the telomeres after each cycle of DNA replication 
(Harley, Futcher et al. 1990; Vaziri and Benchimol 1998).  
 
 
Fig. 11 Cellular senescence (adapted from (Mooi and Peeper 2006)). Senescent 
cells have been observed in normal aging and in cells/tissues of various age related 
pathologies. It is regulated by tumor suppressor pathways like p53 and p16 
INK4A/pRb.  
1.5 Radiation therapy  
Ionizing radiation induces damage to cellular proteins, lipids and nucleic acid. 
The key consequence of ionizing radiation is DNA lesions from which DNA 
double strand breaks (DSBs) have a pivotal role in the decision whether the 
cell would survive the radiation exposure (Hall and Giaccia 2006).  The 
response to DNA damage could lead to activation of DNA repair pathways or 
cell cycle arrest and cell death via apoptosis (Jackson 2001).     
Exposure to ionizing radiation results in the immediate production of free 
radicals that last few milliseconds. In presence of O2, free radicals induce 
intracellular oxidative stress by other reactive oxygen species including 
hydrogen peroxides (H2O2) and organic superoxides (ROOH). These 
processes induce redox sensitive signaling pathways that are suggested to 
induce cytotoxicity, cell cycle delay and genomic instability (Spitz, Azzam et 
al. 2004).  
As it was mentioned in paragraph 1.2, tumor hypoxia is a cause of 
radioresistance duo to lack of O2, as oxygen is required to make permanent 
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and irreparable the DNA damage by ionizing radiation in the radiochemical 
process (Thomlinson and Gray 1955; Overgaard 2007) 
1.5.1 DNA double strand breaks (DSBs) 
Major aim of classical chemo- and radiotherapy in anticancer treatment is the 
eradication of clonogenic tumor cells. The aim of ionizing radiation is to 
induce cellular stress and DNA damage by interacting either directly with the 
DNA or via the formation of reactive oxygen species (ROS) which can 
subsequently damage cellular structures and macromolecules. DNA double-
strand breaks belong to the most serious lesions and are likely to be 
recognized by either of the kinases ATM, ATR or DNA-PKc which represent 
members of the phosphatidylinositol-3-OH-kinase-like family of protein 
kinases (PIKKs) (Fig. 12). ATM and ATR are responsible for the 
phosphorylation of the core histone protein H2AX.  Phosphorylated H2AX, is 
a potent coordinator of DNA-repair mechanisms (Kinner, Wu et al. 2008). In 
case that the DNA damage is too intense, the cell will undergo p53-induced 
apoptosis or cell cycle arrest (Roos and Kaina 2006) 
 
 
 
 
Fig. 12 DNA damage response. (Weberpals, Clark-Knowles et al. 2008)  
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1.6 The aim of the study 
Aim of the current study was to propose a novel strategy to overcome therapy 
resistance of tumor cells under acute hypoxia by using the radical-forming 
endoperoxide Dihydroartemisinin (DHA).  
First, it was important to focus on the efficacy of DHA on solid tumors under 
normoxic and hypoxic conditions. To answer this question, colon cancer cells 
were chosen (HCT116, colo205 and HCT15) for in vitro experiments.  
The next question applied was to elucidate which death pathway was induced 
in solid tumors such as colon cancer and prostate cancer and in Jurkat T-
lymphoma cells, in response to DHA, focusing on apoptosis, necrosis and 
autophagy death modes.  
Moreover, considering the importance of the pro-apoptotic proteins Bax and 
Bak, details of the mithocondrial apoptotic mechanism in response to DHA 
treatment under normoxia and hypoxia were further investigated using colon 
cancer cells, which were either Bax/Bak positive or Bax or/and Bak negative. 
As DHA is a ROS-donor, it was important to evaluate its antineoplastic 
efficacy, focusing on the role of hypoxia for its cytotoxic effects and its 
potentiality in combination therapy with ionizing radiation.  For this purpose, 
HCT116 wt cells treated with DHA under normoxic and hypoxic conditions 
were used. Both short-term and long-term experiments were performed in 
order to understand the involved mechanism which was activated in case of 
the single treatments as well as in combination treatments with radiotherapy
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2 Material & Methods 
2.1 Materials 
Table 1: Materials 
Name   Company 
2-propanol (isopropanol) Sigma 
β-mercaptoethanol Calbiochem 
Acrylamide- / bisacrylamide (Gel 30) solution Roth 
Ammoniumperoxodisulphate (APS) Roth 
Bovine serum albumine (BSA) New England Biolabs 
CCCP Calbiochemy 
Citric acid Roth 
Coomassie Briliant Blue  Fermentas 
Dihydroartemisinin (DHA) Sigma 
Dimethylsulphoxide (DMSO) Sigma 
Phosphate Buffered Saline (PBS) Gibco 
DTT (1,4-dithiothreitol) Sigma 
Ethanol (EtOH) Merck 
Fetal Bovine Cerum (FBS)  Biochrom 
Formaldehyd Merck 
Glycerol Merck 
Glycine Roth 
Guanidinium hydrochlorid 
 
Roth 
Hoechst 33342 Sigma 
HCl Roth 
KCl Merck 
 2 Materials & Methods 
 
 17 
Name   Company 
MgCl2 Merck 
Methanol Merck 
Milk powder Roth 
Mitotracker Red Invitrogen 
Moviol Calbiochem 
Natrium-Citrat Sigma 
NaCl Merck 
 
NaOH Roth 
Paraformaldehyde (PFA) Merck 
Ponceau-S Fluka 
 
Phalloidin FITC TRIZ Sigma 
Propidium iodide (PI) Roth 
Protein marker for SDS page 
 
Fermentas SM1811 
 
Potasium Ferrocyanide 
 
Sigma 
 
Potassium ferricyanide 
 
Sigma 
RPMI 1640 PAA 
 
X-gal Roth 
Sodium dodecyl sulphate (SDS) Roth 
TMRE Molecular probes 
Tris-base 
 
Roth 
 
Tris-HCl Fluka 
Triton X-100 Sigma 
Trypan blue Sigma 
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Name   Company 
Trypsine (0.05 % in EDTA) PAA 
Tween 20 
 
Sigma 
 
TEMED (N,N,N`,N`-Tetramethylethylendiamin) 
 
Roth 
 
Wst – 1   Roche 
 
2.1.1 Chem 
2.1.2 Antibodies 
Table 2: Antibodies 
Name of primary antibody Company 
Anti-β-aktin (Mouse) Sigma 
Anti-Bax (rabbit) Cell Signaling 
Anti-Bcl-xl (rabbit) Cell Signaling 
Anti-Beclin (rabbit) Cell Signaling 
Anti-PARP (rabbit) Cell Signaling 
anti-cleaved PARP(rabbit) Cell Signaling 
Anti-LC3 B (rabbit) Cell Signaling 
Anti CD71 (mouse) Santa Cruz 
Anti AIF (rabbit) Cell Signaling 
Anti-Mcl-1 (Mouse) Cell Signaling 
Anti-HIF-1α (Mouse) BD Biosciences 
Anti-P-H2AX (rabbit) Cell Signaling 
Anti-cytochrome-c (rabbit) Pharmingen 
Anti-caspase-3 (rabbit) Cell signaling  
Anti-cleaved Caspase-3 (rabbit) Cell signaling 
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Name of primary antibody Company 
Anti-Noxa (Mouse) Calbiochem 
Annexin-V FITC ( for FACS) BD Biosciences 
Anti-Puma (rabbit) Cell Signaling 
Anti-Tubulin (rabbit) Cell Signaling 
 
 
Name of secondary antibody Company 
Anti-rabbit-IgG Cy2 
  
Amersham 
Anti-rabbit-IgG HRP (goat) Amersham 
anti-mouse HRP Amersham 
Anti-rabbit HRP Amersham 
 
2.1.3 Technical equipment  
Table 3: Technical equipment 
Name   Company 
Elisa Reader  
 
Synergy HT Bio-Tek 
 
Inverted light microscope 
 
Leica DMIRB 
 
Fluorescence microscope Leica (090-131.001) 
 Confocal-Laser- fluorescence microscope Leica TCS SP 5 
Hypoxia Chamber Invivo2 400, RUSKINN 
Microscope Camera 
 
Zeiss Axiocam 
 
Steril Bench 
 
BDK 
 
Western Blot Developer   Agfa Curix 60 
 
Centrifuge 
 
Jouan CR422 
 
Apotome 
 
Zeiss Axiocam 
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Name   Company 
FACS Calibur Flow Cytometer BD Becton Dickinson 
 
GelCount™ 
 
Oxford optronix 
 
Blotting chamber 
 
Bio Rad 
 
Power supply  
 
Bio Rad 
 
Polyacrilamid gel documantation system Bio Rad 
Laboratory balance KERN 
 
Bench centrifuge Eppendorf 
Gilson pipets Eppendorf 
Cell culture incubator Thermo Sientific 
 
Watter bath Köttermann 
Vortex mixer   Bender & Hobein 
 
 
2.1.4 Other materials 
Table 4: Other materials 
Name   Company 
Pipetboy 
 
Eppendorf  
 
PVDF membrane 
 
Roth 
 
Films  
 
Thermo Sientific 
 
Plastic pipets (5-50ml) 
 
Sarstedt 
Plastic cell culture plates 
 
Corning Incorporated 
 
Whatman filter paper 
 
Schleicher & Schuell 
 
Cell culture flasks (75 / 175 cm²) 
 
Sarstedt 
 
Microscope slide 
 
Engelbrech 
 
Glass coverslips 
 
Roth 
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Name   Company 
Eppendorf tubes (1.5-2.5ml) 
 
Sarstedt 
 
FACS tubes 
 
BD Falcon 
 
 
2.1.5 Software 
Image J 
Photoshop 
Graph Pad prism 
KC4 
ImageQuant 5.2 (GE-Healthcare) 
AxioVision Rel. 4.5 
2.1.6 Buffers and Reagents 
Table 5: Buffer for Immunofluorescence 
PBS 1x  
PFA 2% in PBS 
Triton X-100 0,2% in PBS 
BSA 1% in PBS 
 
Table 6: Buffer for SDS page and Western Blotting  
CST lysis buffer 
62.5mM Tris-HCl (pH 6.8) 
2% (w/v) SDS 
10% (w/v) glycerol 
50mM DTT 
0.01% (w/v) bromophenolblue 
Stacking gel buffer 
60.6g/l Tris-base 
0.4% (w/v) SDS 
pH 6.8 
Running gel buffer 
18.17g/l Tris-base 
0.4% (w/v) SDS 
pH 8.8 
APS 
10% ammoniumpersulphate in 
H2O 
TBS 
150mM NaCl 
10mM Tris-base 
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dH2O 
pH 7.6 
TBS-Tween TBS + 0.05% (v/v) Tween-20 
Blocking buffer (Western Blotting) 5% milk powder in TBS 
Transfer buffer (10x) 
30,3g Tris Mw=121,1 
144g glycine Mw=75,07 
1l H2O 
Transfer buffer (1x) with methanol 
500ml 10x blotting buffer 
1l MetOH 
3.5l dH2O 
Stripping buffer 
62.5mM Tris-base pH 6.2 
2% SDS 
100mM ß-mercaptoethanol 
 
Table 7: Buffer for polyacrylamide gel preparation  
 6% (stacking 
gel) 
12% (running 
gel) 
15% (running 
gel) 
H2O 5.5 ml 13.2 ml 9.2 ml 
Gel 30 1.3 ml 16.0 ml 20.0 ml 
Running gel 
buffer 
--------- 10.0 ml 10.0 ml 
Stacking gel 
buffer 
1.0 ml --------- --------- 
20% SDS 80 µl 400 µl 400 µl 
10% APS 80 µl 400 µl 400 µl 
TEMED 8 µl 16 µl 16 µl 
 
Table 8: Buffer for FACS staining 
Nicoletti Staining Solution (Propidium 
iodide) 
0.1 % sodium citrate 
0.1 % Triton X-100  
50 µg/ml propidium iodide 
 
TMRE 25 nM TMRE in RPMI medium 
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Table 9: Buffer for X-Gal staining solution 
X-gal 1 mg/ml 
Potassium ferrocyanide 5 mM 
Potassium ferricyanide 5 mM 
NaCl 150 mM 
MgCl2 2 mM 
Citric acid  40 mM, pH 6.0 
 
 
2.1.7 Stock preparation  
DHA was dissolved to the final concentration of 40 mM stock in absolute 
EtOH. zVADfmk was dissolved in DMSO in final concentration of 20 mM stock 
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2.2 Methods 
2.2.1 Cell culture 
Colon cancer cell lines (HCT116, Colo 205 and HCT15) were cultured with 
RPMI medium plus 10% FCS (Fetal Calf Serum). In case of the HCT116 cell 
line, other clones were used which were wt or deficient for either Bax or Bak, 
or both negative. Those cells were kindly provided by Professor Dr. Peter 
Daniel (Zhang, Yu et al. 2000).  Jurkat T-Leukemia cells were cultured in 
RPMI medium plus 10% FCS. The Du145 prostate cancer cell line was also 
kindly provided by Professor Dr. Peter Daniel. Du145 cells used for the 
experiments were either DU145 mock (Bax negative/ Bak positive) or Du145 
Bax (which were reexpressing also Bax). The cells are listed in table 1 
 
Table 10: List of the cell lines 
Name Characteristics Medium 
 
HCT116 wt 
Bax/Bak positive, K-RAS 
mutated p53 wt 
RPMI 10% FCS  
HCT116 Bax negative Bax negative / Bak positive RPMI 10% FCS 
HCT116 Bak negative Bax positive /Bak negative RPMI 10% FCS 
HCT116 Duo Bax/Bak 
negative 
Bax /Bak negative RPMI 10% FCS 
JCAM Bak positive Bak positive/Bax negative RPMI 10% FCS 
Du 145 mock Bak positive/Bax negative RPMI 10% FCS 
Du 145 Bax Bax positive/Bak positive RPMI 10% FCS 
Jurkat A3 FADD and caspase-8 positive RPMI 10% FCS 
Jurkat FADD nagative FADD negative RPMI 10% FCS 
Jurkat caspase 8 
negative 
Caspase 8 negative RPMI 10% FCS 
HCT15  P53 mutated RPMI 10% FCS 
Colo205 P53 wt RPMI 10% FCS 
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2.2.2 Passaging of the cells 
Jurkat T-Lymphoma cells were cultured in 75 cm2 flasks for suspension cells and 
passaged at the density higher than 70 %. Adherent cancer cell lines were 
cultured in 75 cm2 flasks for adherent cells. To avoid clonal selections, the cells 
were passaged when 70 % confluence was reached and cultured for not more 
than 10 passages. In case of adherent cells, trypsin-EDTA was used for 
detaching the cells from the plastic. The cells were first washed with PBS in order 
to remove the FCS, which is inhibiting the trypsin. After the washing step, cells 
were incubated for 2-3 minutes with trypsin-EDTA at 37°C. Finally, cells  were 
resuspended with RPMI with 10% FCS in order to inhibit trypsin. The cell 
suspensions were further diluted 1:10 in fresh medium. In case of Jurkat cells, 
the passaging was the same as for adherent cells, except of the trypsinisation 
step. Incubation of the cells was carried out at 37°C, 5% CO2 and a pO2 of 21%. 
 
2.2.3 Counting of the cells 
The cells were diluted 1:1 with trypan blue, placed into a Neubauer counting 
chamber and counted. Trypan blue is a dye that stains cells with damaged 
membranes and can be therefore used in order to distinguish living and dead 
cells. Only the number of living cells (shiny bright) was calculated via the 
following formula: cells/ml = (whole number of cells /4) x (dilution factor) x 104. 
 
2.2.4 Freezing the cells 
The cells were expanded and frozen as follows. The cells were detached with 
trypsin - EDTA and centrifuged in 1000 rpm for 4 minutes at 4°C. The pellet was 
resuspended in freezing medium containing 20% FCS and 10% DMSO. Every 
step was performed on ice (DMSO prevents membrane damage during freezing, 
but could be toxic for the cells at room temperature). The vials were finally placed 
overnight at -80°C in an isopropanol-filled cooling box and the day after 
transferred into liquid nitrogen. Cells were reactivated at any time for the future 
laboratory needs.  
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2.2.5 Cell treatment 
For each experiment, the appropriate amount of cells was plated in order to have 
70 % confluence 24 hours later. At this time, cells were treated. Hypoxia treated 
cells were additionally pre-incubated for 2 hours at 0.2 % pO2 in an hypoxia 
chamber (Fig. 13) in order to allow the cells to adapt to those conditions. DHA 
concentrations applied were in the range of 0-80 M.  To study caspase 
M 
pancaspase inhibitor ZVAD fmk 30 minutes before DHA. In case of combination 
treatments with irradiation, the drug treatment was performed 10 minutes before 
the irradiation. Cells were irradiated with an Isovolt-320 X-ray tube (Seifert-Pantak) 
running at 320 kV, 10 mA, with a 1.65 mm aluminum filter. Irradiation was carried 
out at room temperature at a distance of 75 cm. The effective photon energy was 
~90 kV, the dose rate ~2.76 Gy/min. The irradiation dose applied was in a range of 
0-10 Gy. 
  
 
A B
 
Fig. 13 (A) Hypoxia chamber INVIVO2  400 (B) HIF-1α protein expression was used as a 
marker for hypoxia. Nx=Normoxia, Hx=Hypoxia. 
 
2.2.6 Preparation of cell lysates for SDS – Page 
For whole cell lysates, 0.5x106 cells were plated in 10 cm Petri dishes and 24 h 
later treated with DHA (0-40 µM). After appropriate time points, supernatants and 
cells were collected in the same falcon tube and centrifuged 4 minutes at 1000 
rpm, 4° C. The pellets were resuspended in 1ml of cold PBS, transferred to small 
eppendorf tubes (1.5 ml) and once more centrifuged at 2000 rpm for 3 minutes (4° 
C). Finally, the pellets were resuspended in CST buffer (106 cells/100 µl buffer) 
and the samples were denaturated for 10 minutes at 99° C in hot block. The cell 
lysates were stored at -20° C until use. 
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2.2.7 SDS – Page and western blotting 
The cell lysates were loaded on 12 or 15 % polyacrylamide gels and SDS – PAGE 
was performed under denaturing conditions. In order to determine the molecular 
weight, the appropriate protein marker was used. The gels were set under an 
electrical charge of 80 V until the protein front line had reached the end of the 
stacking gel. Voltage was then shifted at 100 V for the remaining time.  
The proteins were transferred to a PVDF membrane, previously incubated for few 
minutes in methanol, using the sandwich Western Blotting.  The Western Blotting 
transfer chamber was filled with cold 20 % methanol blotting buffer for better 
results the transfer was performed over night at 100 mA at 4° C.   
Following the transfer, to avoid unspecific binding of the antibodies, the 
membranes were blocked in 5 % milk in TBS at room temperature on a shaker. 
Subsequently, the membranes were usually incubated at 4° C over night with the 
primary antibodies appropriately diluted in TBS 5 % BSA or dried milk. The 
membranes were then washed three times with TBS-Tween (0.5 %) and incubated 
for 1 hour at room temperature with the secondary antibodies diluted 1:2000 in 5 % 
milk/TBS. Following the washing steps with TBS-Tween, detection of the desired 
protein bands was conducted with the application of the “Enhanced-
chemiluminescence (ECL) Western Blotting Detection System”.  
 
2.2.8 Evaluation of Western Blots by densitometric analyses  
A densitometric analysis of Western blots was performed by Photoshop software 
as follows. After selection of the desired bands using the Marquee Tool, the 
analyses could be done by recording the grey value mean measurement. The 
same procedure was used for all the bands of interest and for the background, 
which was then subtracted from all the measurements. Finally, the quantifications 
were normalized dividing the obtained values with the values of an internal control, 
such as β–actin, set as 1 or 100 and expressed in the same amount in all the cells. 
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2.2.9 Fluorescence microscopy 
2.2.9.1 Immunofluorescence   
Cells were placed on coverslips in multi-well plates and treated the following day. 
After appropriate time points, the plates were used for immunofluorescence. At 
first, the wells were washed three times with PBS and the cells were then fixed 
with 3 % PFA/PBS for 15 minutes at room temperature. After removal of the 
fixation buffer, the cells were permeabilized for 5-10 minutes with 0.2 % Triton X-
100 in PBS. After 3 washing steps with PBS, unspecific binding sites were blocked 
with 1 % BSA in PBS for 30 minutes. The blocking buffer was removed and the 
cells were subsequently incubated ≥1 hour in a humid chamber at room 
temperature with the respective primary antibodies solution (usually diluted 1: 
100). After three washing steps with PBS (for 2 min), cells were incubated for 45 
minutes incubation with secondary antibodies solution in the dark. Finally, for 
nuclei visualization, 1.5 µM Hoechst 33342 in PBS was added to the cells and 
incubated for 10 additional minutes in the dark. After a final washing step, the 
coverslips were placed inversely onto fluoromount-G mounting medium or mowiol 
on microscope glass slides. The slides were dried and stored at 4° C. The analysis 
of the samples was conducted using the Leica TCS SP5 confocal laser scanning 
microscope. The pictures were taken by Zeiss camera using 63X oil objective.  
Cytochrome-c and LC3 proteins were labeled by cy2-conjugated secondary 
antibody which gives green color and can be detected in GFP filter. In case of γ-
H2AX protein, cy3-conjugated secondary antibody was used, which gives red color 
and can be detected with rhodamine filter set. Finally Hoechst 33342 could be 
detected with the use of Dapi channel.   
 
2.2.9.2 Staining of apoptotic and necrotic cells with Hoechst 33342 
and PI 
To discriminate the type of cell death, Hoechst 33342 and PI staining was 
performed. Hoechst 33342 is a fluorescent dye used for DNA-labelling in 
fluorescence microscopy. This lipophilic dye stains both living and dead cells even 
after fixation. Due to its ability to pass the membranes, it is routinely used to label 
intact or early apoptotic nuclei. Hoechst 33342 is excited by ultraviolet light at 
around 380 nm and emits blue fluorescent light at around 461 nm emissions 
maximum. Propidium iodide, instead, binds to DNA by intercalating between the 
bases with little or no sequence preference and with a stoichiometry of one dye per 
4–5 base pairs of DNA (Suzuki, Fujikura et al. 1997). It is used as a DNA stain for 
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both flow cytometry, to evaluate cell viability or DNA content in cell cycle analysis, 
and microscopy, to visualize the nucleus and other DNA containing organelles 
(Lecoeur 2002). In contrast to Hoechst 33342, PI is membrane impermeable and 
generally excluded from viable cells and therefore, it is used as a marker for dead 
cells. The discrimination between necrotic, apoptotic and viable nuclei is shown in 
Fig. 14.  
  
 
 
Fig. 14 Staining for apoptotic and necrotic cells by Hoechst PI staining. The basic 
principle of this technique is that intact nuclei or early apoptotic nuclei are stained only by 
Hoechst (homogenous blue or fragmented blue respectively), and PI can stain the nuclei 
only in case of necrosis or late apoptosis (homogenous red or fragmented red 
appearance).    
 
For the fluorescence microscopy experiment with Hoechst 33342 /PI staining, cells 
were plated in 12-well plates. The cells were treated the day after plating in 
normoxia or hypoxia. At the appropriate time points, a 1:1 Hoechst 33342 and PI 
mixture was diluted 1:1000 directly in the cell supernatants and subsequently 
incubated in the dark for 10 minutes. Following the incubation time it was possible 
to visualize the nuclei in the fluorescence microscope using Dapi filter.      
2.2.9.3 Mitotracker staining  
MitoTracker Red is a red-fluorescent dye that stains mitochondria in living cells 
and its accumulation is membrane potential-dependent. 
After plating, cells were treated as previously described. Mitotracker solution was 
used at a final dilution of 100 nM in fresh medium, from a stock solution of 1 mM in 
DMSO.  After 30 minutes of incubation at 37 ° C in dark, the plates were washed 
three times 2 minutes with PBS and the cells were fixed with 3 % PFA/PBS and 
counterstained (e.g. Hoechst 33342) or directly analyzed by fluorescence 
microscopy  
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2.2.10  Flow cytometry  
2.2.10.1 Principle 
Flow cytometry is a technique for counting and examining microscopic particles, 
e.g. cells, by suspending them in a stream of fluid and passing them by an 
electronic detection apparatus. It allows simultaneous multiparametric analysis of 
the physical and/or chemical characteristics of up to thousands of particles per 
second. Flow cytometry has many applications in both research and clinical 
practice. Common variation is to physically sort particles based on their properties, 
to purify populations of interest. Cells from a given cell suspension are accelerated 
by high pressure through a capillary thereby creating a regular stream of individual 
cells. The cells then pass an argon laser at 488 nm. The scattering of the incoming 
by the cells light which is detected by photo detectors can be divided into forward 
light scattering (FSC) and side scattering (SSC), which is scatter in a right angular 
compared to the incoming laser beam. While FSC provides a measure for the size 
of the cells, SSC is associated with cellular morphology and intracellular 
granularity. If cells are labelled with a fluorochrome-conjugated antibody or 
fluorescent dye before they are applied to the FACS machine, the incoming laser 
beam has to be adjusted according to the appropriate fluorochrome. The 
fluorochromes are then transferred to an excited state and start to emit light of a 
specific wavelength. By the use of band pass filters emissions of only a specific 
wavelength can be selected for detection. In the FACS Calibur machine (BD 
Transduction Labs) there are three different channels available, termed FL1, 2 and 
3, which detect wavelengths of 537 nm, 597 nm and 650 nm, respectively. 
Typically, the measurements of cell size and granularity are visualized in a dot-
plot, whereas fluorescence intensities are shown as histograms or dot plots. In the 
case of histograms, the y-axis reflects the numbers of cells and the x-axis the light 
intensity.   
 
2.2.10.2 Propidium iodide or “Nicoletti” staining for apoptosis 
and cell cycle analyses 
The “Nicoletti” staining (Nicoletti, Migliorati et al. 1991) provides a FACS-based 
method to measure the cell cycle distribution of a cell population. The method is 
based on the DNA-intercalating dye propidium iodide. Although PI cannot by itself 
permeate membranes, this obstacle is circumvented by the addition of the 
detergent Triton X-100 in a hypotonic citrate buffer, a lipophilic compound that 
accumulates within the cellular and nuclear membranes and thereby 
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permeabilizing them for PI. In the histogram, healthy cells show a distinct pattern 
that is characterized by sharp peaks for diploid cells (G0/G1 phase) and for 
tetraploid cells (G2/M phase). During apoptosis, chromosomal DNA is fragmented 
into pieces of about 185 base pairs or multiples and for this reason, the amount of 
DNA in apoptotic cells is visualized as a characteristic sub-G1 peak (Fig 15). 
 
Fig. 15 Cell cycle distribution from FACS analyses. Typical profiles of cells stained with 
PI in hypotonic buffer containing 0,1 % sodium citrate, 0.05 % Triton X-100 and 50 μg/ml 
PI. DNA content is used to visualize cell cycle by FACS. The sub-G1 peak is attributed to 
apoptotic cells because of the DNA fragmentation 
 
For this set of experiments, an appropriate number of cells was plated in 6-well 
plates and treated after 24 h. Cells were then harvested and centrifuged for 5 min 
at 1000 rpm at room temperature. The supernatant was discarded and the pellet 
resuspended in a hypotonic buffer containing 0.1% sodium citrate, 0.05% Triton X-
100 and 50 μg/ml propidium iodide. After one hour incubation at room temperature 
in the dark, the samples were measured in the fluorescence channel Fl-2. Cellular 
debris has been excluded from the measurement by the appropriate gating 
settings during the evaluation.  
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2.2.10.3 Analysis of mitochondrial membrane potential with 
TMRE staining  
The cationic, lipophilic dye tetramethylrhodaminethylester (TMRE) accumulates at 
the inner mitochondrial membrane in cells with an intact proton gradient and 
membrane potential (∆ψm) (Scaduto and Grotyohann 1999). 
TMRE has therefore been used in FACS analysis as a detector for living cells with 
intact mitochondria (FL-2 channel). During apoptosis, the ∆ψm decreases or 
become even completely lost due to mitochondrial damage and TMRE can no 
longer accumulate in the cells. In the histogram, viable cells are characterized by a 
stable peak of high fluorescence intensity. Apoptotic cell populations show a 
decreased fluorescence signal derived from the TMRE, staining resulting in a shift 
to the left of the original peak.  
The procedure was conducted by harvesting treated cells after the desired 
incubation time by centrifugation (5 min, 1000 rpm at room temperature). The 
supernatant was carefully discarded and the pellet resuspended in 25 nM TMRE in 
cell culture medium. The cell suspension was then incubated for 30 minutes at 37° 
C and subsequently measured in the FACS Calibur. 10 µM carbonyl cyanide m-
chlorophenylhydrazone (cccp) for complete depolarization of the mitochondria, 
was added 10 minutes before the sample measurement as a positive control for 
low ∆ψm (Fig 16). 
 
 
 
 
Fig. 16 Cells stained with TMRE. Typical profiles of cells stained with TMRE and 
analyzed by flow cytometry using FL-2 channel for detection. Cells with intact mitochondria 
(living cells) are characterized by high ∆ψm (high fluorescence intensity) and apoptotic 
cells are characterized as cells with low ∆ψm (low fluorescence intensity).   
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2.2.10.4 Annexin V / PI 
In apoptotic cells, the membrane phosphatidylserine (PS) is translocated from the 
inner to the outer plasma membrane, thereby exposing to the external cellular 
environment (BD biosciences 2008) also during the subsequent necrosis, which 
can be then distinguished using the PI staining. Annexin V is Ca2+ concentration 
dependent that has a high affinity for PS. Annexin V is routinely tested in flow 
cytometric analyses. Cells were incubated for 15 minutes in the dark with FITC-
coupled annexin V and PI in binding buffer. At the end the cells were further diluted 
with binding buffer to reach 1x105 cells, and measured within 1 hour (FL-1= 
annexin V and FL-2= propidium iodide; BD Transduction Labs).  
 
2.2.10.5 Activation of Bax  
Activation of Bax and Bak is essential in mitochondrial apoptotic pathway. Bax 
activation involves a conformational change which allows its translocation to the 
mitochondrial membrane. To detect this activated form, a specific antibody binding 
to the N terminus of Bax was used (Nechushtan, Smith et al. 1999). 
Cells were plated in 6-well plates and harvested at the appropriate time points after 
treatment. Cells were permeabilized for 30 minutes on ice with 0.1 % Triton 
X100/PBS, and after a washing step with PBS, incubated for 15 minutes at room 
temperature in the blocking solution (10 % FCS/PBS) and stained for 30 minutes 
on ice with the first antibody Bax Nt solution (1:1000 in 10 % FCS/PBS).  The cells 
were then washed with 10 % FCS/PBS and incubated with the secondary anti 
rabbit conjugated cy2 antibody (1:1000 in 10 % FCS/PBS) for 30 minutes on ice 
and in the dark.  Finally, the cells were washed and resuspended in 100 μl PBS 
and measured by flow cytometry in FL-1 channel. Unstained cells, cells only with 
the primary or the secondary antibody and isotype control were used to validate 
the results. 
 
2.2.11 Colony formation assay  
To investigate the long term effects of DHA treatment, such as the eradication of 
clonogenic tumor, colony formation assay was performed. This method is 
especially important in cancer research laboratories to determine the effect of 
drugs or radiation on proliferating tumor cells (Hoffman 1991). 
Colonies were counted (≥50 cells/colony) under the microscope (5-fold 
magnification). The surviving fraction of treated cultures was calculated with the 
following formula: survival fraction= colonies counted/cells seeded x (PE/100). 
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Plating efficiency is given by the number of colonies counted divided by the 
number of cells seeded x 100. The survival curves were established by plotting the 
log of the surviving fraction versus the treatment dose.  
Here I employed two principles of colony formation assay, the direct and delayed 
plating.  
 
2.2.11.1 Direct plating 
In the direct plating assay, 200 to 1600 cells/well were plated in 6-well plates. After 
24 h in normoxia the cells were treated in normoxia or hypoxia and further 
incubated approximately 10 days until the colonies were formed. In case of 
hypoxia, the cells were incubated in hypoxia chamber only for 24 h after treatment 
and subsequently incubated in normoxia. The experiment was stopped according 
to the controls, in the way that the colonies were not confluent and was still 
possible to discriminate single colonies in the plates. At the end of the experiment, 
cells were fixed in 3.7 % formaldehyde and 70 % ethanol and stained with 0.05 % 
coomassie brilliant blue. 
  
2.2.11.2 Delayed plating 
In case of delayed plating the cells were plated and treated into the flasks and after 
24 h the cells were trypsinized and plated again (200-16000 cells/well). The 
experiment was stopped after 10 days with the same procedure mentioned for the 
direct plating.  
 
2.2.12  WST-1 Assay 
The stable tetrazolium salt WST-1 is cleaved to a soluble formazan by a complex 
cellular mechanism. This bioreduction is largely dependent on the glycolytic 
production of NAD(P)H in viable cells (Berridge, Herst et al. 2005). Therefore, the 
amount of formazan dye formed directly correlates to the number of metabolically 
active cells in the culture and the color of the cells supernatant was changed 
dependent from the density of the cells. The absorbance can be detected using a 
scanning multi-well spectrophotometer (ELISA reader). The measured absorbance 
at 450 nm wavelength directly correlates to the number of viable cells.  
The experiment was performed according to manufacture instructions of Roche 
applied Science. 
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2.2.13 Pulsed-field gel electrophoresis (PFGE) 
Asymmetric field inversion gel electrophoresis (AFIGE) is a form of PFGE suitable 
for the separation of relatively large DNA-fragments (Stamato, Guerriero et al. 
1993). The agarose cylinders with the lysed cells were loaded on 0.5 % agarose 
gels prepared with 0.5 µg/ml ethidium bromide. Gels were run in 0.5 x TBE for 40 h 
at 8°C. Cycles of 50 V (1.25 V/cm) for 900 s into the direction of DNA-migration 
alternated with 200 V (5.0 V/cm) for 75 s into the opposite direction. Subsequently, 
gels were scanned with a fluorescence scanner and the fractions of DNA released 
(FDR) from the cylinders into the lanes were quantified with ImageQuant 5.2 (GE-
Healthcare). Dose response curves were plotted as FDR versus radiation dose. 
These curves were used to calculate the equivalent Gy dose (Deq) values for each 
FDR that was measured at a given repair time point and the repair kinetics were 
plotted as Deq versus time. 
 
2.2.14 DNA repair  
Ten minutes prior to irradiation, cells were treated with 5 µM of DHA, as required 
by the experimental protocol.. After irradiation, cells were promptly returned to the 
incubator. At specific times thereafter, cells were collected, cooled down to 4° C, 
embedded in 3 x 5 mm low melt agarose cylinders at 1 x 105 cells/cylinder and 
subsequently lysed. For cells that were used to obtain dose response curves, the 
cells were first embedded in agarose blocks, cooled down to 4° C, and then 
irradiated and lysed. 
Lysis took place in lysis solution (100 mM EDTA, 50 mM NaCl, 10 mMTris, 2 % N-
lauroylsarcosine and 0.2 mg/ml protease) for 18 h at 50° C. After lysis, cylinders 
were washed in washing solution (100 mM EDTA, 50 mM NaCl, 10 mM TRIS) for 1 
h at 37° C and then treated with washing buffer containing 0.1 mg/ml ribonuclease 
A at 37 °C for 1 h (PFGE and DNA repair experiments were performed in 
collaboration with Prof. G. Iliakis and Dr. M. Moscariello). 
 
2.2.15 Senescence staining 
Senescence staining detects β-galactosidase activity at pH 6 in cultured cells. β-
galactosidase activity at pH 6 is present only in senescent cells and is not found in 
immortal proliferating cells (Dimri, Lee et al. 1995). 
The cells were plated for senescence in 60 cm Petrι dishes a 2.7x105 per dish. 
Cells were treated with DHA under normoxic or hypoxic conditions and the plates 
were further incubated for the required time points. The cells were first washed two 
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times with PBS and subsequently fixed with 3 % of PFA/PBS for 5 minutes. The 
washing step was repeated after the fixation. At the end, the x-gal staining solution 
was placed on the cells and incubated for 16 h at 37o C without CO2. The cells 
were washed with H2O two times and observed under light microscopy. As a 
positive control, lung fibroblasts were used, since these cells become senescent in 
tissue culture when they reach confluence 
2.2.16 Statistical data analyses 
Experiments were performed at least three times and data were compared using a 
two-tailed unpaired t-test, with a P value ≤0.05 considered as significant, using a 
GraphPad InStat software (La Jolla, USA).
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3 Results 
3.1 Antineoplastic efficacy of DHA 
The first question was: whether DHA induced eradication of colon cancer cells in 
normoxia and hypoxia.  The antineoplastic efficacy of DHA was studied in human 
colon cancer cells (HCT116, Colo205 and HCT115). For this purpose WST-1 
assay (viability assay) was performed in those cells under normoxic and hypoxic 
conditions.  
3.1.1 DHA induces reduction of viability in colon cancer cells 
Human colon cancer cell lines HCT116, Colo205 and HCT15 were treated with 
DHA (0-80 μΜ) for 48 h. DHA efficacy was analyzed employing the WST-1 assay.   
DHA significantly reduced the number of viable cells in dose-dependent manner in 
all three tested cell lines compared to the untreated solvent control (EtOH) (Fig 
17). The toxic concentrations of DHA ranged from 10-80 µM DHA for HCT15 cells 
and 20-80 µM DHA for Colo205 and HCT116. Significant differences regarding to 
cell viability were observed in all three tested cell lines. Cell viability reduced to 50 
% in HCT15 cells in response to 10 µM DHA treatment, reaching significant 
difference in comparison to its solvent control (p< 0.001).  
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Fig. 17  DHA induces reduction in the number of viable cells in normoxia. HCT15, 
Colo205 and HCT116  cells were treated with increasing concentration of DHA. After 48h 
of incubation, WST-1 assay was performed. Ethanol was used as a solvent control of the 
drug. The experiments were performed in triplicate.  The normalization was considered 
from ethanol controls. P values were calculated using unpaired two tailed t-test. (*) P < 
0.05; (**) P < 0.01; (***) P < 0.001  
 
In addition, cell viability was further decreased in dose-dependent manner 
reaching 20 % viability in response to higher dose of DHA (80 µM). In contrast to 
HCT15, the other two cell lines, Colo205 and HCT116, were more resistant to 
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DHA, with Colo205 to be the most resistant. However, cell viability was reduced in 
dose dependent manner reaching significant differences (20-80 µM DHA).       
To gain insight into the putative drug activity, similar experiments were performed 
incubating the cells under hypoxia for 48 h. 
The results showed similar antineoplastic activity of DHA under normoxic and 
hypoxic conditions (Fig.17-18). In contrast to normoxic conditions, in case of 
hypoxia in HCT15 cells, cell viability was significantly reduced at 10 µM DHA but 
was not further decreased in dose dependent manner until the maximum dose of 
80 µM DHA. Colo205 cells showed similar response to the antineoplastic efficacy 
of DHA under both normoxic and hypoxic conditions. Finally, HCT116 cells were 
more sensitive to DHA treatment under hypoxic conditions than under normoxic 
conditions. Cells treated with lower DHA concentrations (10 and 20 µM) showed 
similar reduction of cell viability (50%). In contrast to hypoxia, the same DHA 
concentrations in normoxia reached 80 and 60% of viable cells respectively. 
Higher DHA concentrations (40 and 80 µM) induced strong reduction of viable cells 
under both normoxic and hypoxic conditions reaching significant difference (p< 
0.001) in comparison to solvent control. However, under hypoxic conditions DHA 
shoed higher efficacy.       
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Fig. 18 DHA is active under hypoxia and is cytotoxic in colon cancer cells. Colon 
cancer cell lines were treated as described for normoxia experiment. Cells were 
incubated for 48 h in hypoxia and after were analyzed by WST-1 test. The experiment 
was performed at least in triplicate. The graphs represent the percentage of living cells 
evaluated from WST-1 test. The normalization was considered from ethanol controls.  P 
values were calculated from unpaired two tailed t-test. (*) P < 0.05; (**) P < 0.01; (***) P < 
0.001. 
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To compare the antineoplastic efficacy of DHA under normoxic and hypoxic 
conditions, cells treated with 40 µM DHA from fig. 17-18 were further analyzed. As 
it was previously described, colo205 cells showed no differences between 
normoxia and hypoxia in response to DHA treatment. In case of HCT15 cells, DHA 
significantly reduced cell viability under normoxic conditions in comparison to the 
hypoxic conditions (P < 0.05). Interestingly, HCT116 showed a higher sensitivity to 
DHA under hypoxic conditions; however, the reduction of viable cells did not reach 
significant difference (fig. 19).   
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Fig. 19 DHA is active under both normoxic and hypoxic conditions and induces 
antineoplastic efficacy. Data represent the percentage of living cells treated with 40 µM 
DHA from the Fig.17 and 18. The normalization was considered from ethanol controls. 
Significant test was performed according to unpaired two tailed t-test. ns= not significant, 
(*) P < 0.05. Hx=hypoxia and Nx=normoxia. 
 
3.1.2 DHA reduces cell proliferation 
WST-1 assay gives the information about the amount of viable cells. However, it 
does not give the information about the absolute amount of living/dead cells. To 
discriminate between the dead and viable cells and to determine whether DHA had 
a cytotoxic or a cytostatic effect, trypan blue staining was performed with HCT116 
cells under normoxic and hypoxic conditions (Fig. 20).  
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Fig. 20 DHA is cytostatic under normoxic and hypoxic conditions. HCT116 cells were 
plated 2x10
5
/well in 6 well plates and 24 h later were treated with DHA. At 48 h and 72 h 
the cells were harvested and stained with trypan blue. (A) The graphs represent the 
number of living cells in normoxia (black bars) and hypoxia (white bars). (B) The graphs 
represent the number of dead cells under normoxic (black bars) and hypoxic (white bars) 
conditions. The experiment was performed in triplicate. (*) P < 0.05; (**) P < 0.01; (***) P < 
0.001 unpaired two tailed t-test.   
 
DHA had a cytostatic effect in both normoxic and hypoxic conditions. Especially, 
hypoxia alone could induce a cytostatic effect; however the difference was not 
significant. At lower drug concentrations the cells were able to grow after 72 h 
compared to 48 h, however the number of viable cells was significantly reduced in 
comparison to the control at both time points. At higher drug concentrations, cells 
were close to their plated number of cells 2x105 in normoxia.  
In case of hypoxia, proliferation inhibition exerted by DHA did not reach statistical 
significance in comparison to the ethanol controls. In addition, DHA did not 
increase the number of dead cells under both conditions at 48 h and 72 h time 
points. This indicated that DHA acts more as a cytostatic than as a cytotoxic agent. 
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3.1.3 DHA induces apoptosis and necrosis  
Trypan blue staining gives the information about the living and the dead cells, 
however, it is not discriminating the apoptotic cells which still have intact 
membranes. To define whether DHA induced apoptosis or necrosis, tumor cells 
were further analyzed by fluorescence microscopy and flow cytometry.  
Experiments with Jurkat E6.1 leukemic T cells were performed focusing on 
apoptosis induction. The cells were harvested 12 and 24 h after DHA treatment. 
For apoptosis detection, annexin V/PI staining was used as described before. 
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Fig. 21 DHA –induced apoptosis is dose and time dependent.  Jurkat E6.1 cells were 
plated and 2 h later treated with DHA. After 12 and 24 h treatment the cells were harvested 
and analyzed by flow cytometry. Apoptotic cells were characterized the cells which was ere 
either only Annexin annexin V positive (early apoptotic) only or annexin V plus PI positive 
(late apoptotic and necrotic). The experiment was performed in triplicate (Means ± SD.; n = 
3; two-tailed t-test: (*), P < 0.05; (**), P < 0.01; (***), P < 0.001 (Handrick, Ontikatze et al. 
2010) 
 
Early apoptotic cells (annexin V positive only) and late apoptotic or necrotic cells 
(annexin V and PI positive) were quantified. DHA induced significant apoptosis and 
necrosis in dose and time dependent manner (Fig. 21). Apoptosis was strongly 
upregulated after DHA treatment already at 10 µM DHA at 12 h time point (30 % of 
apoptotic cell) and further increased in dose dependent manner reaching 
significant difference between 10 and 20 µM DHA (P < 0.01). In parallel, cells in 
late apoptosis and necrosis (annexin V and PI positive cells) were also increased 
after treatment in dose dependent manner. At 24 h time point, apoptosis was 
upregulated in response to 10 µM DHA (30 %) however, it did not increase further 
at higher dose of DHA (20 and 40 µM), while late apoptosis and necrosis were 
significantly increased. At 12 h time point DHA induced maximum 20% of late 
apoptotic and necrotic cells, on the other hand at 24 h time point DHA induced 50 
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% of late apoptotic and necrotic cells indicating time dependency. These results 
indicate that DHA-induced apoptosis is an early event and it reaches the maximum 
at 12 h time point in response to 10-40 µM DHA. At 24 h time point most of the 
cells are either late apoptotic or necrotic. Interestingly, the combination of annexin 
V positive with annexin V/PI positive cells, reaches 90 % at 24 h time point in 
response to 40 µM DHA.  
3.1.4 DHA induces apoptosis via intrinsinsic pathway 
To further investigate the mechanism of antineoplastic action of DHA and to gain 
insight into the involved pathway, Jurkat A3 cells, or either FADD-negative or 
caspase-8 negative were treated with DHA and examined for apoptosis induction. 
FADD and caspase-8 are the key regulators in the extrinsic apoptosis pathway. To 
investigate the importance of caspases, the pancaspase inhibitor zVAD was used.  
Hoechst and propidium iodide (PI) staining showed that DHA was able to induce 
apoptosis independent of  caspase 8 and FADD. At 12 h time point DHA (10 µM) 
induced apoptosis in Jurkat A3 as well as in Jurkat caspase 8 and FADD negative 
cells. Interestingly, zVAD in combination with DHA completely abrogated apoptosis 
induction and necrosis could be observed (Fig. 22 A). FACS results with 
annexin/PI staining confirmed the Hoechst and PI data, showing high apoptosis 
and necrosis induction in Jurkat A3 cells in dose dependent manner in comparison 
to the ethanol control, reaching significant difference (P < 0.001) in response to 40 
µM DHA. In case of caspase 8 negative cells apoptosis and necrosis were also 
highly upregulated. Jurkat FADD negative cells were the most resistant in 
apoptosis and necrosis induction in response to DHA treatment and did not reach 
significance but in case of the lower concentration of 10 µM DHA corresponded to 
18 % of cells positive for annexin and PI, reaching significance in comparison to 
ethanol control (P < 0.05) (Fig. 22 B). This result suggested that DHA – induced 
apoptosis takes place even if the extrinsic apoptotic pathway is blocked. In 
addition, it also demonstrated that the caspases play a pivotal role in DHA-induced 
apoptosis as zVAD blocked apoptosis in DHA treated cells.  
.  
3.1.5 DHA induces apoptosis in normoxia and hypoxia 
To evaluate the importance of apoptosis for DHA action under normoxic and 
hypoxic conditions, FACS analyses was performed employing HCT116 colon 
cancer cells. Apoptosis was quantified by analyzing the amount of cells with low 
mitochondrial membrane potential (TMRE staining) and the amount of cells with 
DNA fragmentation (Nicoletti staining).  
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Fig. 22 DHA induces apoptosis via intrinsic apoptotic pathway. (A) Jurkat A3, Jurkat 
FADD-/- and Jurkat caspase 8-/- T  lymphoma cell lines were plated and treated with DHA 
alone or in combination with 20 µM zVAD. 12 h later cells were stained with Hoechst and 
propidium iodide and were analyzed by fluorescence microscopy. Scale bar corresponds to 
100 μm (B) Apoptosis was studied by FACS analyses in Jurkat A3, FADD-/- and caspase 
8-/- cells 24 h  after DHA treatment (0-40 µM). Annexin V and propidium iodide positive 
stained cells were considered as apoptotic or late apoptotic and necrotic cells. Graph 
represents means from three independent experiments ±SD. Statistical analysis was 
performed according to unpaired two tailed t-test in comparison to untreated controls. (*) P 
< 0.05; (**) P < 0.01; (***) P < 0.001 and ns=not significant. (Handrick, Ontikatze et al. 
2010) 
 
As shown in fig. 23 A, DHA induced significant depolarization of the mitochondrial 
membrane potential in both normoxia and hypoxia in dose and time dependent 
manner. However, the level of DNA fragmentation was induced in dose dependent 
manner and was not further increased at 48 h time point under both conditions 
(Fig. 23 B).  
Cells with low Δψm were significantly increased in normoxia after treatment with 
12.5 and 25 μΜ DHA at both 24 and 48 h time points, reaching 80 % (24 h) and 90 
% (48 h) of the total cell number at 25 µM DHA (P < 0.001) in comparison to the 
ethanol control. In addition, 25 µM DHA induced significantly higher amount of 
A 
B 
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cells with low Δψm in comparison to 12.5 µM DHA (P < 0.01) at 24 h (from 60 % to 
80 %) and 48 h (from 70 % to 90 %) time points (Fig. 22 A). Cell with low Δψm 
were also significantly increased under hypoxic conditions in response to DHA 
treatment at both time points however, were less than under normoxic conditions.  
DNA fragmentation was significantly increased at 24 and 48 h time points in 
treated cells with DHA (12.5 and 25 µM) under both normoxic and hypoxic 
conditions. DNA fragmentation was already highly induced at 12.5 µM DHA 
concentration (60 %), however it did not further increase at higher DHA 
concentration. The same was observed under hypoxic conditions at 24 and 48 h 
time points (Fig. 23 B). As it can be shown in Fig. 23 C, 25 µM DHA significantly 
increased the number of cells with low Δψm (apoptosis) under normoxic conditions 
in comparison to hypoxic conditions at both time points. Similarly, DNA 
fragmentation was significantly lower under hypoxic conditions in contrast to the 
normoxic conditions in response to DHA but only at 24 h time point. In case of 48 h 
time point, DNA fragmentation was lower under hypoxic conditions, however the 
difference did not reach statistical significance.                                                                       
 3 Results 
 
 45 
A
B
C
Normoxia
Hypoxia
HCT116 24 h
EtOH 12.5 25 EtOH 12.5 25
0
20
40
60
80
100
***
***
**
***
***
DHA [µM]
HCT116 48 h
EtOH 12.5 25 EtOH 12.5 25
0
20
40
60
80
100
***
***
**
***
***
*
DHA [µM]
c
e
ll
s
 w
it
h
 l
o
w
m
 [
%
]
HCT116 24 h
EtOH 12.5 25 EtOH 12.5 25
0
20
40
60
80
100
*** ***
*
DHA [µM]
S
u
b
 G
1
 [
%
]
HCT116 48 h
EtOH 12.5 25 EtOH 12.5 25
0
20
40
60
80
100
*** **
***
DHA [µM]
S
u
b
 G
1
 [
%
]
HCT116
25 Nx 25 Hx 25 Nx 25 Hx
0
20
40
60
80
100
* **
24 h 48 h
DHA [µM]
s
p
e
c
if
ic
m
 [
%
]
HCT116
25 Nx 25 Hx 25 Nx 25 Hx
0
20
40
60
80
100
*
24 h 48 h
ns
DHA [µM]
s
p
e
c
if
ic
 S
u
b
 G
1
 [
%
]
c
e
ll
s
 w
it
h
 l
o
w
m
 [
%
]
 
Fig. 23 HCT116 cells are sensitive to DHA-induced apoptosis in normoxia and 
hypoxia.  HCT116 wt cells were plated and treated with DHA under normoxic (white bars) 
and hypoxic conditions (black bars). 24 and 48 h later the cells were harvested and 
analyzed by flow cytometry. (A) HCT116 wt cells were analyzed for cells with low 
mitochondrial membrane potential (Δψm). For this purpose TMRE staining was used. (B) 
PI in hypotonic citrate buffer was used for staining of DNA content. Sub G1 peak which 
corresponds to fragmented DNA, was quantified and considered as amount of apoptotic 
cells. (C) The graphs represent the absolute values of treated cells with 25 μM DHA 
corrected with their ethanol controls. The quantifications were performed for Δψm and Sub 
G1 for both normoxic  and hypoxic conditions, at 24 and 48 h time points. The experiments 
were performed in triplicate.  A statistical analysis was performed according to unpaired 
two-tailed t-test. (*) P < 0.05; (**) P < 0.01; (***) P < 0.001 and ns=not significant. 
 
Another characteristic of apoptosis execution is Bax translocation to the 
mitochondria and the release of cytochrome c from mitochondria to the cytoplasm. 
Cytochrome c release leads to the caspases activation. To analyze at which time 
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point apoptosis was executed, whole cellular extracts were prepared at different 
time points (4 h and 12 h) under normoxic and hypoxic conditions (Fig. 24).  DHA 
induced cleavage of caspase-3 and of its substrate, PARP, at 12 h time point in 
normoxia. In case of hypoxia, DHA induced lower amount of caspase-3 and PARP 
cleavage at this time point. 
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Fig. 24 DHA - induced apoptosis is decreased in hypoxia. Whole cell lysates of 
HCT116 treated with DHA in hypoxia and normoxia were analyzed at 4 h and 12 h. For 
apoptosis detection, specific antibodies which detect cleaved form of caspase 3 and PARP 
were used in Western Blot. The experiments were done in triplicate and the representative 
blot is shown. 
 
Due to apoptosis induction at 12 h time point, it was next focused on Bax activation 
and cytochrome c localization at 12 h under normoxic and hypoxic conditions. Bax 
activation was monitored using a specific antibody, Bax NT which binds to the 
activated form of Bax in mitochondria. For the current study FACS analysis was 
used.  
Bax was activated in both normoxic and hypoxic conditions after DHA treatment 
leading to approximately 90 % of activation (Fig. 25 A).  On the other hand, 
cytochrome c release was monitored by immunofluorescence using a specific 
antibody. DHA led to cytochrome c release under both normoxic and hypoxic 
conditions (Fig. 25 B).  
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Fig. 25 DHA induced Bax activation and cytochrome c release in normoxia and 
hypoxia. (A) HCT116 cells were treated for 24 h with DHA and analyzed by FACS using 
an antibody specific for the activated Bax form. The shift of the peak to the right was 
identified as Bax activation. (B) HCT116 wt cells were treated with 25 µM DHA and 12 h 
later, cells were fixed and analyzed by immunofluorescence. For cytochrome c detection, 
primary antibody against cytochrom c was used. Anti rabbit conjugated cy2 antibody was 
used and subsequently detected by GFP filter. The experiment was performed in triplicate. 
A statistical analysis was performed according to unpaired two-tailed t-test. Results 
represents means ±SD (**) P < 0.01.  Scale bar corresponds to 10 µm 
 
DHA treatment disrupted mitochondrial membrane potential and maybe for this 
reason, mitotracker was not detectable under hypoxic conditions after DHA 
treatment, corroborating the results of the TMRE staining (Fig. 23 A). In both 
ethanol controls in normoxia and hypoxia, cytochrome c was localized into the 
mitochondria as cytochrome c and mitotracker had same localization.   
Further experiments with Hoechst and PI staining were done in order to describe 
which was the mechanism of death (apoptotic or necrotic).  
From evaluations of three independent experiments, it was recognized that DHA 
induced significant apoptosis and necrosis after 24 h under normoxic conditions.  
DHA induced further increase in necrosis at 48 h time point reaching significant 
difference in comparison to the 24 h time point. On the other hand apoptosis and 
necrosis were not significantly increased after 24h by DHA treatment in hypoxia, 
but apoptosis was significantly increased after 48 h, thus indicating a delay in DHA 
action under hypoxic conditions with respect to apoptosis induction.  However, 
DHA did not further increase necrosis after 48 h.  This experiment showed that 
DHA induced apoptosis under both normoxic and hypoxic conditions. However, 
necrosis was taking place only under normoxic conditions after DHA treatment and 
was further increased over time. Finally, in hypoxia, DHA induced lower amount of 
necrotic cells which was not increased over time (Fig. 26).  
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Fig. 26 DHA induces apoptotic and necrotic death in HCT116 wt. (A) HCT116 cells 
were treated and incubated for 24 h in normoxia or hypoxia. The cells were stained with 
Hoechst (blue) and PI (red) and visualized by fluorescence microscopy. Scale bar 
represents 100 µm. (B) The apoptotic and necrotic cells were quantified at 24 and 48 h 
time points from three independent experiments. Black bars correspond to normoxia and 
white bars to hypoxia. Statistical analysis was done by unpaired two-tailed t-test. (*) P < 
0.05; (***) P < 0.001 and ns=not significant.    
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Fig. 27 DHA induced apoptosis and necrosis in HCT15 and colo205 cells in normoxia 
and hypoxia. (A) HCT15 and colo205 cells were plated and treated with DHA (0-50 µM) 
under normoxic and hypoxic conditions. 24 h later cells were stained with Hoechst and PI 
and analyzed by fluorescence microscopy. Representative pictures from one of three 
independent experiments are shown. Scale bar corresponds to 100 µm. (B) Apoptotic and 
necrotic cells were quantified from three independent experiments. Graphs represent 
means ± SD. Significance test was performed between the treated and untreated samples 
as well as between normoxic and hypoxic conditions. Statistical analysis was done by 
unpaired two-tailed t-test. (*) P < 0.05; (**) P < 0.01; (***) P < 0.001. Nx=normoxia and 
Hx=hypoxia 
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Apoptosis and necrosis was also studied in HCT15 (p53 mutated cells) and 
colo205 colon cancer cells. The aim was to test whether DHA acts also in other 
colon cancer cells in regards to apoptosis and necrosis. To investigate the 
mechanism of cell death, Hoechst and propidium iodide staining was carried out 
under normoxic and hypoxic conditions.  
As it is shown in Fig. 27, DHA induced significant apoptosis and necrosis in HCT15 
cells in both normoxia and hypoxia in a dose-dependent manner. Apoptosis 
induction was higher in these cells under hypoxic conditions reaching the 
maximum at 25 µM concentration and, at higher dose, necrosis was more 
prominent. However, at 50 µM, DHA led to a higher amount of necrosis in 
normoxia in comparison to hypoxia.  
Apoptosis was induced in colo205 in dose-dependent manner in normoxia and 
hypoxia but apoptosis was significantly higher in hypoxia (25 µM DHA) 
corresponding to 40 % of counted cells and to 12 % in normoxia. Necrosis was 
highly increased at 50 µM DHA under both conditions, however, necrosis was 
significantly increased in hypoxia in comparison to the same concentration in 
normoxia. In detail, necrosis induction under normoxic conditions reached 12 % 
and in hypoxia 40 % of counted cells.     
 
3.1.6  DHA – induced apoptosis is Bax/Bak dependent 
To investigate further the intrinsic apoptotic pathway, HCT116 cells with or without 
expression of Bax or Bak or both were used. Cells were treated with different DHA 
concentrations for 24 and 48 h under normoxic conditions. At the appropriate time 
points, cells were harvested and analyzed for apoptosis by flow cytometry using PI 
staining in low citrate buffer in order to characterize the fragmented DNA (Sub-G1 
peak).  
DNA fragmentation was increased significantly in cells expressing Bax and Bak in 
dose-dependent manner and reached 70 % of apoptosis induction in response to 
50 µM DHA.  Especially, Bax was playing important role in apoptosis induction, as 
the HCT116 Bax negative cells showed decreased apoptosis  levels (25 % in 
response to 50 µM DHA) compared to Bax proficient but Bak negative cells (50 % 
in response to 50 µM DHA). Similarly to HCT116 Bax negative cells, the same 
amount of apoptosis induction was observed in double negative Bax/Bak cells in 
response to 50 µM DHA (Fig. 28 A).  DHA did not induce additional apoptosis over 
the time as it can be seen in Fig. 28 B.  Calculating the specific apoptosis in DHA 
treated cells, it was identified that DHA induced apoptosis in Bax dependent but 
Bak independent manner (apoptosis induction in response to DHA was increased 
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as follows: wt >Bak-/->>Bax-/-=Bax/Bak-/-). HCT116 wt and HCT116 Bax negative 
cells were further analyzed by Western blotting focusing on apoptotic markers 
such as PARP cleavage, which is a caspase-3 substrate during the apoptosis. 
DHA induced PARP activation in dose and time dependent manner and apoptosis 
was strongly delayed in absence of Bax (Fig. 28 C).  
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Fig. 28 Bax and Bak influence apoptosis induction after DHA treatment.  (A) 
HCT116 cells which were either wt or Bax or/and Bak negative, were treated with 
different DHA concentrations. 24 h later the cells were analyzed for apoptosis by flow 
cytometry. (B) Specific apoptosis was calculated by extracting ethanol control. Graph 
represents the specific apoptosis from FACS analyses for 24 h and 48 h time points. (C) 
HCT116 wt and HCT116 Bax negative cells were plated and treated with increasing dose 
of DHA and incubated for 12 and 24 h. Whole cell lysates were performed and analyzed 
for caspase activation by Western blotting. (D) Expression of pro-apoptotic proteins Bax 
and Bak were tested by Western blotting analyses. Experiment for FACS analyses and 
western blots were performed in triplicate. For Western blots representative pictures are 
shown. A statistical analysis was performed according to unpaired two-tailed t-test. (*) P < 
0.05; (**) P < 0.01; (***); P < 0.001. 
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Importance of Bax and Bak in DHA-induced apoptosis was shown also in Du145 
prostate cancer cells which do not express p53. Du145 mock cells which are Bak 
positive but Bax negative showed no significant apoptosis induction (Sub G1 and 
Δψm) in response to DHA treatment. In contrast to the Du145 mock cells, the 
Du145 Bax positive cells showed significant apoptosis in DHA treated cells. 
Especially, high dose of DHA (50 µM) led to a significant amount of cells with low 
mitochondrial membrane potential (70 % of cells with low Δψm) and to a significant 
DNA fragmentation at the same DHA concentration (15 % of cells with fragmented 
DNA) (Fig. 29 A). From these results, it could be concluded that Bax and not Bak 
are responsible in DHA-induce apoptosis in both HCT116 cells and in Du145 cells. 
To confirm the result and to discriminate between apoptosis and necrosis induction 
in response to DHA, DU145 cells were used for apoptosis and necrosis detection 
via Hoechst and PI staining. 
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Fig. 29 DHA-induced apoptosis is Bax dependent. (A) Du145 mock and Du145 Bax 
positive cells were treated with DHA and 48 h later cells were harvested and analyzed for 
apoptosis with FACS analysis and (B) Du145 mock and Du145 Bax positive cells were 
treated with DHA and 48h later were stained with Hoechst/PI. Graphs represent the 
quantifications of apoptotic and necrotic cells. The experiments were performed at least 
three times. A statistical analysis was performed according to unpaired two-tailed t-test. 
Results represents means ±SD (*) P < 0.05; (**) P < 0.01 (***); P < 0.001 and ns. not 
significant. 
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In the absence of Bax, DHA induced significant death by necrosis (P < 0.001). 
However, in presence of Bax, DHA was inducing predominantly apoptosis. (Fig. 29 
B). To summarize, Bax and not Bak seemed to be essential in apoptosis induction 
in response to DHA in the colon cancer cells. Loss of Bax led to increased necrotic 
death in DHA response in Du145 model.   
3.1.7 DHA-induced apoptosis depends on Bax/Bak also under 
hypoxic conditions 
To further investigate the importance of the proapoptotic Bcl2- proteins Bax and 
Bak, HCT116 cells which are either lacking Bax or Bak or both were treated with 
25 µM DHA for 24 h under normoxic and hypoxic conditions. Apoptosis was 
analyzed using FACS (Δψm and Sub G1) and fluorescence microscopy (Hoechst 
and propidium iodide staining).  
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Fig. 30 Apoptosis is significantly reduced under hypoxic conditions in a Bax/Bak 
dependent manner.  (A) HCT116 wt, Bax negative, Bak negative, and Bax/Bak negative 
monitored with FACS analysis (SubG1 and Δψm). (B) Graphs represent the controls from 
the same experiments under normoxic and hypoxic conditions.  A statistical analysis was 
performed according to unpaired two-tailed t-test. Results represent means of specific 
values ±SD (*) P < 0.05; (**) P < 0.01; (***) P < 0.001. (*) was used for comparison 
between different cells to the HCT116 wt and (†) was used to compare normoxic to the 
hypoxic conditions. 
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At the level of the mitochondria, DHA did not show significant differences between 
normoxic and hypoxic conditions. However, significant differences were observed 
between the HCT116 wt and the other cell clones (HCT116 Bak -/-, HCT116 Bax -
/-, and HCT116 Bax/Bak -/-) under both normoxic and hypoxic conditions. DHA-
induced depolarization of the mitochondrial membrane potential required Bax/Bak 
presence. In case of loss of Bax or/and Bak, cell with low Δψm were significantly 
reduced in response to the same concentration of DHA (25 µM). Interestingly, 
under hypoxic conditions Bak but not Bax showed to play an important role in 
induction of mitochondrial depolarization. HCT116 Bak -/- and HCT116 Bax/Bak -/- 
cells showed to induce similar result in depolarization of the mitochondria. 
However, HCT116 Bak -/- cells did not reach significant difference in comparison 
to the HCT116 wt. At the level of DNA fragmentation, in contrast to the normoxic 
conditions, DHA showed significant reduction in Sub G1 under hypoxic conditions 
for all HCT116 clones. In addition Bax and Bak played a pivotal role in DHA-
induced DNA fragmentation as shown in Fig. 30 A right panel, where the Sub G1 is 
significantly lower in Bak or/and Bax negative cells in comparison to the HCT116 
wt. In hypoxia Bax and Bak showed also an importance in DHA-induced apoptosis, 
however the difference between the wt and the HCT116 clones did not reach 
statistical significance. Finally, in case of DNA fragmentation Bax presence 
showed to be responsible for apoptosis induction in response to DHA. Loss of Bax 
resulted to show similar amount of cells in Sub G1 compared to the HCT116 
Bax/Bak negative cells (20 and 15 % respectively). The ethanol treated cells were 
not showing changes in the amount of apoptosis under both normoxic and hypoxic 
conditions (Fig. 30 B).    
Hoechst and PI staining was performed in order to examine the mechanism of 
death induced by DHA in HCT116 wt, HCT116 Bak or and Bax negative. Cells 
were plated in 12-well plates and treated in normoxia or hypoxia with 25 µM DHA. 
24 h later the cells were stained and analyzed by fluorescence microscopy.  
DHA induced apoptosis in all cell lines, however apoptosis induction was 
significantly reduced when Bax or Bak were missing. Necrosis was observed only 
in HCT116 wt and it was not detectable in other cell lines (Fig. 31 A). 
From the Hoechst and PI staining results it was possible to confirm that DHA 
induced apoptosis in a Bax dependent manner. In addition, apoptosis was reduced 
under hypoxic conditions in all the cell lines however it was still Bax dependent 
(Fig 31 B) but it did not reach significant difference in normoxia. Finally, necrosis 
was highly induced in HCT116 wt as shown in Fig. 26 B, and not observed in cell 
lines lacking Bax/Bak.  
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Fig. 31 DHA induces cell proliferation down-regulation and apoptosis 
induction in normoxia and hypoxia in Bax/Bak dependent manner. (A) HCT116 
wt, Bax or/and Bak negative. cells were treated with 0-
hypoxia. 24 h later cells were stained with Hoechst and PI. Apoptosis and necrosis 
were identified by fluorescence microscopy. Representative pictures are shown. 
Scale bar corresponds to 100 µm (B) Apoptotic cells were quantified. Graph 
represents means from absolute values for apoptotic cells from three independent 
experiments ± SD. The experiment was done in triplicate Statistical analyses was 
performed according to unpaired two-tailed t-test. (*) P < 0.05; (**) P < 0.01, ns= not 
significant.  
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3.1.8 DHA induces reduction of HIF-1 alpha expression in the 
absence of Bax  
In cancer, both hypoxia and mutations in oncogenes as well as in tumor 
suppressor genes increase HIF-1 activity. HIF-1 target genes have been 
identified, and many of these are associated with angiogenesis, invasion, 
and metastasis (Semenza 2003). Considering this, it was investigated 
whether DHA could induce downregulation of HIF-1 alpha expression at the 
protein level. For this purpose the HCT116 cell clones were used. First, 
HCT116 wt, HCT116 negative for Bax or Bak and HT116 Bax/Bak negative 
cells were analyzed for HIF-1α relative expression over the time in an 
environment containing 0.2% of O2 (Fig. 32). The Western-blot analysis 
showed that all the HCT116 cell clones do not express HIF-1α under 
normoxia but only under hypoxia. Under hypoxia, HIF1  protein level 
increased in a time dependent manner in all the cell lines. For all the cell 
lines HIF-1α protein levels were decreased after 24 h in hypoxia (Fig. 32)   
The same experiment was performed with DHA treated cells compared to 
the ethanol controls. At early time points (4 h), DHA induced no changes in 
HIF-1α expression in comparison to the ethanol control. In contrast to the 4 h 
time point, at 12 h time point, DHA down-regulated HIF-1α expression in Bax 
or Bak negative cells. The drug did not influence the HIF-1α expression in 
HCT116 wt cells (Fig. 33). 
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Fig. 32 HIF-1α expression over the time in HCT116 cells. HCT116 wt, Bak-/-, 
Bax-/- and Bax/Bak-/- cells were treated with hypoxia for different time points (0-24h) 
and whole cell extracts were performed. HIF-1α expression was analyzed by 
Western blots. Experiment was performed two times and representative blot is listed. 
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Fig. 33 DHA downregulates HIF-1α protein expression, in response to loss of 
Bax/Bak.  HCT116 wt, Bak neg, Bax neg. and Duo Bax/Bak neg. cells were treated 
with DHA or ethanol for 4 and 12 h under hypoxic conditions. 12 h ethanol control 
was used as a negative control for HIF-1α expression under normoxic conditions. 
Densitometric analysis of the current blot and the ratio of HIF-1α/β-actin were 
calculated and used for the graph. The experiment was performed two times and the 
representative blots were used.   
3.1.9 DHA is cytostatic and cytotoxic for HCT116 cells  
From previous results in HCT15, colo205 and HCT116 wt cell lines, it was 
shown that DHA induces significant cell proliferation inhibition and reduces 
the viability of the treated cells under normoxic and hypoxic conditions (Fig. 
17-Fig. 20). Therefore it was important to analyze whether DHA treatment 
might induce reduction in cell viability and inhibition of cell proliferation in 
Bax/Bak dependent manner. To this aim, the viability and proliferation 
capacity of HCT116 cells, which were either wild type or Bax or/and Bak 
negative, were analyzed by WST-1 assay (Fig 34) and by trypan blue 
staining (Fig. 35).     
WST-1 assay using HCT116 wt, Bax negative, Bak negative or Bax/Bak 
double negative cells, was performed in normoxia and hypoxia and the 
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experiment was stopped after 24 h or 48 h. Fig. 34 A represents graphs with 
the percentage of values normalized by the ethanol controls at 48 h time 
point.  
The results showed that, in normoxia, DHA induces reduction of living cells in 
dose dependent manner and it is influenced by the loss of Bak or Bax. 
Indeed, HCT116 wt showed strong reduction of viable cells in dose 
dependent manner and the maximum effect was achieved at 40 µM DHA 
which corresponded to 30 % of living cells in normoxia. Instead, under 
hypoxic conditions, DHA induced strong proliferation inhibition and only at 
higher concentrations of 40 and 80 µM, DHA induced further reduction of cell 
viability (20 % of viable cells at 80 µM DHA). Compared to the wt cells, the 
Bak negative cells were less sensitive under both normoxic and hypoxic 
conditions. In normoxia cell viability showed similar pattern of concentration 
dependency as for the HCT116 wt. At the higher concentrations (40 and 80 
µM DHA), DHA treatment achieved the same OD values (viability) which 
corresponded to 20 % of viable cells. In hypoxia, DHA induced mostly cell 
proliferations inhibition at lower DHA concentration until 20 µM and at higher 
DHA concentrations, such as 40 and 80 µM, cell viability was reduced to 15 
%. HCT116 Bax negative or HCT116 Bax/Bak negative cells showed to be 
more resistant to DHA under both normoxic and hypoxic conditions 
compared to the HCT116 wt and the Bak negative cells. As it is 
demonstrated in Fig 34 B, there were no significant differences observed 
between the normoxic and hypoxic conditions in cell viability in response to 
20 and 40 µM DHA in all the tested cell lines. However, cell viability was 
significantly reduced in dose dependent manner under both normoxic and 
hypoxic conditions in HCT116 wt. In case of Bax negative or Bak negative 
cells, the significant difference was only observed in normoxia but no longer 
in hypoxia. In addition the HCT116 duo Bax/Bak negative cells, showed to be 
the most resistant and did not reach significant difference in viable cells 
between the 20 and 40 µM DHA under both conditions.    
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Fig. 34 DHA induces proliferation inhibition to HCT116 model in normoxia and 
hypoxia. (A) HCT116 cells were plated in 96 well plates and treated in normoxia or 
hypoxia. 48 h later the absorbance of the supernatant was measured by ELISA 
reader after 1 h with WST-1 compound. Graphs show the percent of absorbance 
compared to untreated cells. The experiments were made in triplicate. (B) The 
percent of the OD values (living cells) were compared to the percent of the hypoxic 
OD values for 20 and  40 µM DHA  (C) The LC50 of DHA in HCT116 were 
calculated from the formula with four parameters: LC50: y = (a-d)/(1+(x/c)
b
) + d   
given from the fitting of the curve by KC4 software. All the experiments were 
performed in triplicate ± SD. Statistical analysis was performed according to 
unpaired two-tailed t-test (*) P < 0.05; (**) P < 0.01; (***) P < 0.001; ns=not 
significant.   
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Finally, the LC50 values were calculated and it was observed that HCT116 
wt was the most sensitive cell line to DHA-induced cell death (reduction of 
viable cells) under both normoxic and hypoxic conditions. Interestingly, under 
hypoxic conditions HCT116 wt were even more sensitive to DHA treatment 
(8 µM DHA). Loss of Bak or/and Bax, showed significant resistance to the 
DHA-induced death and it was even higher under hypoxic conditions (Fig. 34 
C). In hypoxia, loss of Bak and Bax causes higher LC50 values of DHA 
concentration (ca. 60 µM). 
These results suggest that Bax is essential to induce reduction of cell viability 
in HCT116 cells under normoxic conditions; however, Bax and Bak are 
needed under hypoxic conditions to induce cell death. DHA is cytotoxic in 
normoxia and cytostatic in hypoxia in HCT116 cells. 
To corroborate our findings and to exclude potential artifacts of the WST-1 
assay under hypoxic conditions, a trypan blue test was performed using 
HCT116 wt and HCT116 Bax/Bak negative cells (Fig. 35). The cells were 
stained with trypan blue and at the 48 h time point; cells were counted under 
the microscope.  
Treatment with DHA inhibited cell proliferation in HCT116 wt and Duo 
Bax/Bak negative clones under normoxic conditions. Hypoxia treatment 
alone showed also an impact in cell proliferation in both cell lines (cells in 
hypoxia were proliferating slowly). However, the effect was not significant 
(Fig. 33 A). DHA did not further diminish cell proliferation in the HCT116 wt, 
and was not significantly reduced in comparison to its control under hypoxic 
conditions. Moreover, treatment of HCT116 Bax/Bak negative cells induced 
significant down-regulation in cell proliferation in comparison to the control in 
hypoxia. Moreover, DHA did not induce significant increase of the dead cells 
in HCT116 wt cells under both normoxic and hypoxic conditions. In contrast, 
Bax/Bak negative cells showed a significant increase in dead cells in 
response to DHA in normoxia, but not in hypoxia (Fig. 35 B).    
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Fig. 35 DHA was cytoxic for HCT116 wt and HCT116 Bax/Bak -/- cells in 
normoxia and hypoxia. (A) Cells were plated (2x10
4
) and treated with DHA (0-25 
µM) in normoxia (black bars) and hypoxia (white bars) and after 48 h cells were 
harvested and stained with trypan blue in order to discriminate between the living 
and the dead cells.  Cells were counted under the microscope. The intact cells which 
were not positive for trypan blue staining were characterized as living cells. The 
graphs contain the absolute numbers of cells counted from three independent 
experiments. (B) Trypan blue stained cells were characterized as dead cells. The 
graphs represent the percentage of dead cells. The graphs represent means ±SD 
from triplicate experiments. Statistical analyses was performed according to 
unpaired two-tailed t-test (*) P < 0.05; (**) P < 0.01; (***) P < 0.001.  
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In order to investigate whether DHA-induced cell proliferation inhibition was 
due to cell cycle arrest, cell cycle regulation was further investigated. For 
these experiments, the cell cycle distribution of HCT116 wt and HCT116 
Bax/Bak negative cells was analyzed by flow cytometry. The cells were 
treated in normoxia and hypoxia and 24 h later they were analyzed for the 
cell cycle distribution. A FACS analysis was performed with propidium iodide 
staining in hypotonic citrate buffer. The results from three independent 
experiments are represented in Fig. 36.  
Results from the FACS analyses showed a significant decrease in G1 phase 
in HCT116 wt in response to DHA under normoxic conditions in comparison 
to the ethanol control. The effect was altered by an increase in the number of 
cells in G2/M phase however, didn’t reach a significant difference.  Hypoxia 
alone did not influence the cell cycle distribution in comparison to normoxia 
in HCT116 wt cells. Under hypoxic conditions HCT116 wt cells were 
increased in G1 phase in response to DHA, however not significantly. The 
G1 increase was leading to a small decrease in G2 phase, and S phase was 
not influenced in response to DHA treatment. In case of HCT116 Bax/Bak 
negative cells, no significant change in G1 was observed and only a small 
increase in G2 phase was detected in normoxia. In addition, G1 and G2 
phase were also not changed in normoxia. DHA significantly dropped the S 
phase under hypoxic conditions. Hypoxia alone did not influence the cell 
cycle distribution in comparison to the normoxic conditions. 
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Fig. 36 DHA cause cell cycle arrest in HCT116 clones. HCT116 wt and HCT116 
Bax/Bak negative cells were plated and treated with DHA. At 24h time point, 
cells were harvested and analyzed for the cell cycle distribution by FACS. The 
quantifications from the different cellular phases from FACS analyses under 
normoxic and hypoxic conditions were taken according to histogram plots from three 
independent experiments. Graphs represent the percentage from different phases of 
cell cycle in HCT116 wt (A) and HCT116 Bax/Bak negative cells (B) The apoptotic 
cells were excluded from the measurements (G1+S+G2 phases were considered to 
100 %). The graphs represent means ±SD from triplicate experiments. Statistical 
analysis according to unpaired two-tailed t-test (*) P < 0.05, (**) P < 0.01.  
 
3.1.10 Bax and Bak are critical for DHA – induced death of 
clonogenic tumor cells in normoxia but not in hypoxia  
All the experiments which were described until now were short term assays 
which, differently from long term assays such as the colony formation assay, 
have limited clinical relevance. A clonogenic assay is a technique to study 
the effectiveness of specific agents on the survival and proliferation of cells. 
It is especially important in cancer research laboratories to determine the 
effect of drugs or radiation on proliferating tumor cells (Hoffman 1991).  
In a first part, the addressed question was whether DHA could induce 
clonogenic death under normoxic and hypoxic conditions to be able to 
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subsequently identify the importance of the pro-apoptotic proteins, Bax and 
Bak in clonogenic death induction.  
Thus, in the current study, the antineoplastic efficacy of DHA in HCT116 
colon cancer cells under normoxic and hypoxic conditions was examined. 
HCT116 wt, HCT116 Bak negative, HCT16 Bax negative and HCT116 
Bax/Bak negative cells were plated for colony formation assay. In case of 
hypoxia, the cells were preincubated in a hypoxia chamber for 2 h treated 
with DHA and after 24 h the treated and control cells were further incubated 
under normoxic condition for other 10 days, until the colonies were formed. 
The results from three independent experiments were analyzed and the 
survival fractions were calculated (Fig. 37). As shown in the graph, DHA 
induced clonogenic death in dose dependent manner in all the cell clones 
under both normoxic and hypoxic conditions. The results demonstrate that 
Bax and Bak are required to signal the clonogenic death in response to DHA 
treatment. The cells which were lacking either Bax or Bak or both were more 
resistant to DHA-induced death of clonogenic tumor. Interestingly, under 
hypoxic conditions the cells were sensitive to DHA-induced death and this 
result was Bax/Bak independent. That suggested that DHA might act using 
alternative mechanisms in order to induce clonogenic death.      
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Fig. 37 DHA induces clonogenic death in normoxia and hypoxia. HCT116 cells 
were plated for colony formation assay and treated with 0-20 µM DHA under 
normoxic or hypoxic conditions. After 24 h in hypoxia, corresponding plates were 
further incubated in normoxia. The experiment was stopped after 10 days of 
incubation. The surviving fraction (SF) was calculated from counted colonies (>50 
cells) divided with plated number of cells. Values were corrected by plating efficiency 
of the cells treated with ethanol.  
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3.1.11 DHA induces autophagy in HCT116 cells  
The results obtained from colony formation assay led to the hypothesize that 
DHA may induce Bax/Bak independent clonogenic death by using an 
alternative death mechanism in hypoxia. Autophagy was then examined as 
an alternative death mode in response to DHA treatment. To investigate 
whether DHA induced autophagy, HCT116 wt and HCT116 double Bax/Bak 
negative cells were used in the following experiments in normoxia and 
hypoxia.  
To study the autophagy, microtubule-associated protein1 light chain 3 (MAP-
LC3 or LC3) specific antibody was used as a marker for autophagy induction. 
The localization of LC3 in the specific organelles autophagosomes is an 
indicator for cells undergoing autophagy. During the process LC3 is cleaved 
and LC3-II translocates into the autophagosomes. Therefore, 
immunofluorescence staining was used to identify the localization of LC3 in 
the cells after treatment with DHA. 
The result from the immunofluorescence experiments showed that HCT116 
wt cells had similar autophagic behavior in normoxic and hypoxic conditions. 
The untreated cells (ethanol controls) showed basic levels of autophagy and 
after DHA treatment, autophagy was slightly increased.  However, it was not 
significantly increased in comparison to the ethanol solvent control from 
counting the punctuated structures which correspond to the autophagic 
vacuoles. 
In contrast to the wild type, the Bax/Bak negative cells did not show any 
autophagy in ethanol control in normoxia and hypoxia, however autophagy 
was observed in response to 25 µM DHA treatment in both conditions (Fig. 
38). 
LC3 localization in autophagosomes increased in HCT116 wt cells under 
both conditions. In contrast, a cytoplasmic LC3 localization was found in 
HCT116 Bax/Bak negative cells in normoxia and hypoxia. DHA induced 
significant increase in LC3 levels in autophagosoms in both HCT116 wt and 
Bax/Bak negative cells under normoxic and hypoxic conditions.  
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Fig. 38 DHA induces autophagy in Bax/Bak independent manner in normoxia 
and hypoxia. HCT116 wt and HCT116 Duo Bax/Bak neg. cells were treated with 
DHA (0-25 μΜ DHA) and 12 h later were analyzed by immunofluorescence, using a 
specific antibody which binds to LC3. The experiment was performed two times and 
the representative pictures were used. Scale bar corresponds to 10 μm.  
 
By Western blot analysis of the LC3II proteins, it was confirmed that 
autophagy was induced at basic levels, approximately 5 %, in HCT116 wt 
cells under both normoxic and hypoxic conditions (Fig. 39). DHA induced 
significant amount of autophagy in dose dependent manner leading to 
maximum amount of autophagy to 40 % in HCT116 wt in normoxia. DHA 
induced also significant increase in autophagy in hypoxia, however it was 
lower (25 %) in comparison to normoxia. In contrast to the HCT116 wt, in 
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HCT116 Bax/Bak negative cells, autophagy was lower in normoxia (10 % at 
12.5 µM DHA) but in hypoxia it was highly up-regulated (40 % at 12.5 µM 
DHA).  
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Fig. 39 Autophagy is Bax/Bak-dependent in normoxia but not in hypoxia (A) 
HCT116 wt and HCT116 Bax/Bak -/- cells were treated with DHA in normoxia and 
hypoxia and 24 h later the cells were harvested and the whole cell lysates were 
prepared. For autophagy characterization, a specific antibody against LC3 was used 
recognizing LC3I and LC3II form. The experiment was performed three times and 
the representative blots are shown. (B) Graphs represent densitometric analysis 
from the current blot.  
 
3.2 Combination treatment with ionizing radiation 
Hypoxic tumor microenvironment leads to limited success of radiotherapy. 
Molecular O2 must be present during the radiation exposure in order to fix the 
DNA damage and produce free radicals (Hall and Giaccia 2006). As 
Dihydroartemisinin (DHA) is radical-forming endoperoxide, the idea was to 
overcome therapy resistance of tumor cells under acute hypoxia by using 
this drug for combination treatments with ionizing radiation.    
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3.2.1 DHA in combination with ionizing radiation in HCT116 
model 
In a first part, it was tested whether DHA in combination with radiotherapy 
was synergistically inducing apoptosis in solid colon cancer cells in normoxic 
and hypoxic conditions.  
For the combination experiments, HCT116 wt cells were used and treated 
with DHA, ionizing radiation or the combination of both treatments. In case of 
combination, DHA was added 10 minutes before the radiation. Apoptosis 
was studied by Western blot or FACS analysis. To elucidate the efficacy of 
combined treatment under hypoxia, the experiments were done under both 
normoxic and hypoxic conditions.  
FACS analysis after 48 h revealed that DHA alone induced significant 
apoptosis in HCT116 wt cells under normoxic and hypoxic conditions, as it 
was already described in 3.1.5 (Fig. 40). Ionizing radiation was able to 
induce a high amount of apoptosis of HCT116 wt cells under normoxic 
conditions (45 % cells in Sub G1 in response to 10 Gy) and under hypoxic 
conditions (35 % cells in Sub G1in response to 10 Gy) but it was lower in 
comparison to DHA alone (50 % in normoxia and 45 % in hypoxia cells in 
Sub G1). In combined treatments of DHA and irradiation, apoptosis induction 
was exactly like DHA alone under normoxic conditions. However, under 
hypoxic conditions, apoptosis was significantly increased in combined 
treatment in comparison to irradiation alone but not to the drug alone.  DHA 
alone was more prominent in apoptosis induction than ionizing radiation. On 
the one hand apoptosis was significantly reduced under hypoxic conditions in 
case of low DHA concentration or low irradiation dose (not significantly) in 
comparison to normoxia. On the other hand, higher dose of both treatments 
(25 µM DHA and 10 Gy) were sufficient to induce similar amount of 
apoptosis under both conditions (Fig. 40 A). To confirm the results from 
FACS data, caspases activation was further investigated by Western blot 
analysis. Caspase-3 activation was determined 24 h after treatments with 
DHA, ionizing radiation and the combination of both treatments. DHA alone 
showed high amount of PARP cleavage which is a caspase-3 substrate in 
normoxia. Interestingly, ionizing radiation alone achieved small amount of 
apoptosis induction. However, in combination treatments, PARP cleavage 
was significantly increased in comparison to the control or irradiation alone 
but not more than DHA alone in normoxia. Caspase-3 cleavage was hardly 
detectable in DHA treated cells and in combined treated cells with irradiation. 
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Caspase-3 activation was abolished under hypoxic conditions, in all the 
treatments (Fig. 40 B).   
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Fig. 40 Combination treatment induces non synergistic apoptosis in HCT116 
wt cells. HCT116 wt cells were treated with DHA, ionizing radiation or with 
combination of both.  (A). A FACS analysis was performed at 48 h time point of 
treatments in normoxia and hypoxia. The graphs represent means ±SD from 
triplicate experiments. Statistical analysis was performed according to unpaired two 
tailed t-test (*) P < 0.05; (**) P < 0.01; (***) P < 0.001. Experiments were performed 
in triplicate. The (*) without associated lines, represent the significant difference in 
comparison to the ethanol control. (B) Whole cellular extracts were prepared   after 
24 h of incubation under normoxic or hypoxic conditions. The experiment was 
performed in triplicate and representative blot was used.  
 
However, in combination treatments, PARP cleavage was significantly 
increased in comparison to the control or irradiation alone but not more than 
DHA alone in normoxia. Caspase-3 cleavage was hardly detectable in DHA 
treated cells and in combined treated cells with irradiation. Caspase-3 
activation was abolished under hypoxic conditions, in all the treatments (Fig. 
40 B). 
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Fig. 41 DHA-induced autophagy is stronger in hypoxia and in combination 
treatments. HCT116 wt cells were plated for whole cell lysates and treated under 
normoxic or hypoxic conditions. At 24 h time point, cells were harvested and whole 
cell lysates were prepared. The experiment was performed in duplicate. The 
densitometric analysis was made from representative blot by Photoshop 
.    
 
As shown from previous results, apoptosis was not increased in combination 
treatments more than in DHA alone. Therefore, the question remains, 
whether the combination treatment could induce autophagy. To analyze 
autophagy in combination treatments with ionizing radiation, whole cell 
lysates were prepared from HCT116 wt cells under normoxic and hypoxic 
conditions. LC3 cleavage was analyzed by Western blots and the ratio of 
LC3II (associated with autophagosomes) to LC3I (associated with 
cytoplasm), was calculated and considered as indicative for autophagy 
induction. Preliminary results from the densitometric analysis showed that 
DHA-induced autophagy was upregulated under normoxic and hypoxic 
conditions but autophagy was much higher in hypoxia especially at 25 µM 
DHA. In combination treatments, autophagy was further increased compared 
to the single treatments (Fig. 41).   
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3.2.2 Combination treatment induced persistence of DNA 
double strand breaks (DBS)   
As described in 1.2.7, the ionizing radiation induces cellular stress and DNA 
damage.  DNA double-strand breaks belong to the most serious lesions and 
correlate with cell killing.  At this point it was interesting to test whether DHA 
induced DNA damage and whether DNA damage could be further increased 
in combination treatments with ionizing radiation. 
For these experiments HCT116 wt cells were used. The cells were treated 
with 5 µM DHA and the dose of 10 Gy of ionizing radiation was applied. For 
combination treatments (DHA + irradiation), DHA was added 10 minutes 
before the irradiation. 
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Fig. 42 Combination treatments induced DNA damage persistence. (A) HCT116 
wt cells were treated with DHA or ionizing radiation or the combination of both. The 
cells were analyzed by immunofluorescence and representative pictures from 30 
minutes time point are shown. (B) The γ-H2AX foci were quantified and represented 
on graph ±standard error. At least 3 pictures were analyzed and quantified. The 
results are from 2 experiments and the significance test was performed from the 
means and standard errors from number of γ- H2AX foci per approximately 100 
nuclei. Statistical analysis was performed according to unpaired two-tailed t-test  
(***) P < 0.001.  
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Repair kinetics was monitored by immunofluorescence detecting a specific 
marker for DNA double strand breaks, the phospho H2AX (γ-H2AX). Usually 
DNA damage is repaired within two hours after radiation (Wierowski, Thomas 
et al. 1984). The results from immunofluorescence showed that DHA induced 
a minimal DNA damage which was not significant in contrast to the ethanol 
solvent control and it was not influenced over the time. In case of ionizing 
radiation alone, the DNA damage was significantly increased over the time. 
In combination treatments the γ-H2AX foci were rapidly increased at 30 
minutes time point (100 γ-H2AX foci) (Fig. 40 A), however, the number of 
cells with DNA double strand breaks were decreased over the time until 4 
hours time point and up-regulated again after 8 hours (Fig. 40 B). Irradiation 
induced significantly less γ-H2AX foci at early time points until time point 4 h 
in comparison to the combination treatment and from this time point (4 h) 
combination treatments showed to induce the same number of γ-H2AX foci 
until 8 h time point. 
To confirm the results from immunofluorescence, the same samples were 
also analyzed by pulsed field gel electrophoresis (PFGE). This method is 
widely used to detect the induction and repair of double-strand breaks.  
The results showed a delay in repair kinetics when the cells were treated in 
combination with DHA and ionizing radiation in comparison to radiation alone 
until the time point 4 h (Fig 43). 
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Fig. 43 Combination treatment with ionizing radiation shows delay in repair 
kinetics at early time points.  From HCT116 wt cells in Fig. 42, agarose plugs 
within which cells have been embedded and lysed were runned by PFGE for 40 
hours. The fraction of DNA released (FDR) from the agarose plug was quantified for 
each time point with ImageQuant 5.2 (GE-Healthcare). The experiment was 
performed two times. The DNA in gel plugs were loaded in 3 different gels (3 
identical replicates) in each experiment.  
 
 
3.2.3 Combination treatment leads to increase of clonogenic 
death in HCT116 wt cells  
The next aim was to investigate the antineoplastic efficacy of DHA in 
combination treatment in HCT116 wt focusing on long term assays. For this 
purpose, HCT116 wt cells were plated for colony formation assay. The cells 
were treated with different DHA concentrations or different doses of ionizing 
radiation or the combination of both treatments. The experiments were 
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performed in normoxia according to the protocol of delayed plating 
(described in 2.2.11). 
At the end of the experiment, the colonies were visualized under the 
microscope and studied to evaluate the number as well as the shape of the 
colonies. As shown in the Fig. 44, the cells which were irradiated with 4-6 Gy 
showed a big swollen cytoplasm and “giant” nuclei. This phenotype was not 
seen in cells treated with 0-10 µM DHA alone. However, higher dose of 20 
µM DHA and the combination treatments also showed an increase in the 
number of “giant” cells.  
The colonies were quantified and normalized to their ethanol controls. The 
calculated survival fractions are presented in fig. 45 A. Ionizing radiation (4-6 
Gy) led to a significant eradication of colonies, showing sensitivity in those 
cells to ionizing radiation. On the other hand when cells were treated in 
combination with DHA, the number of colonies was reduced even more than 
when ionizing radiation alone was applied (Fig. 45 B). Interestingly, DHA 
presence influenced HCT116 wt cells response to the treatment. In more 
details, when HCT116 wt cells were plated directly for the colony formation 
assay and DHA was present all the time during the experiment, the survival 
fraction was decreased in dose dependent manner. In contrast, when the 
cells were plated, treated with DHA and 24 h later re-plated for the colony 
formation assay (delayed plating), they were able to recover and the survival 
fraction was significantly higher compared to the survival fraction from the 
direct plated cells (Fig. 45 C). 
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Fig. 44 Ionizing radiation in combination with DHA leads to an altered cell 
phenotype. HCT116 wt cells were plated for colony formation assay according to a 
protocol for delayed plating described (2.2.11.2). 800 cells were plated in 6 well and 
after 10 days the experiment was stopped and the colonies were fixed and stained 
with coomassie blue. The colonies were analyzed under the microscope and the 
pictures are the representative from two independent experiments. Each colony 
represents a combination of 3 or more pictures together. The scale bar corresponds 
to 100 μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 Results 
 
 76 
A.
B.
C.
0 Gy 4 Gy2 Gy
XRT
XRT+10 µM 
DHA
0
20
40
60
80
100
120
140
0Gy 2Gy 4Gy 6Gy
n
u
m
b
e
r 
o
f 
c
o
lo
n
ie
s
XRT
XRT+10 µM DHA
*
0,001
0,010
0,100
1,000
10,000
0 5 DHA 10 DHA 15 DHA 20 DHA
S
F
HCT116 wt 
Delayed Plating
HCT116 wt 
Direct Plating
0,001
0,010
0,100
1,000
0 2 Gy 4 Gy 6 Gy
S
F
HCT116 wt XRT
HCT116 wt XRT+5 µM DHA
HCT116 wt XRT+10 µM DHA
 
Fig. 45 Combination treatment of ionizing radiation and with DHA leads to 
eradication of clonogenic HCT116 wt cells. (A) HCT116 wt cells were plated for 
colony formation assay with delayed plating. 200 – 64000 cells were plated and 
incubated for 10 days until the colonies were grown. The survival fraction was 
calculated after counting the number of colonies and normalized by plating 
efficiency. Survival fractions were represented from two independent experiments. 
(B) Colonies were quantified and displayed on a graph from correspondent plates 
with 800 cells plated.  Statistical analysis was performed according to unpaired two-
tailed t-test (**) P < 0.01; (***) P < 0.001. (*) corresponds to XRT (C) The Survival 
fraction from direct plating from fig. 37 was compared to the survival fraction from the 
delayed plating in DHA treated HCT116 wt cells. 
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4 Discussion 
4.1 DHA Treatment 
4.1.1 DHA induces growth inhibition and apoptosis 
induction under normoxic and hypoxic conditions 
This study showed that DHA induced inhibition of cell proliferation and 
apoptosis in dose and time dependent manner in human colon cancer cells 
(HCT15, Colo205 and HCT16), in Jurkat T-lymphoma cells and in prostate 
cancer cells (Du145). These data corroborate findings obtained by other 
groups in distinct cells, as in a study on human hepatocellular carcinoma 
cells (HCC) (Hou, Wang et al. 2008) and HUVECs cells (Chen, Zhou et al. 
2003). Most of the studies on artemisinin derivatives activity have been 
performed under normoxic conditions and little is known about artemisinin 
derivatives activity under severe hypoxia.  The current study showed for the 
first time, that ROS-donor DHA was active also in severe hypoxia at 0.2 % 
of O2, although higher doses of DHA were necessary to achieve significant 
apoptosis. Interestingly, a recent study in human dermal microvascular 
endothelial cells (HMEC-1) demonstrated that DHA induced apoptosis was 
decreased at 1% O2.  However, DHA activated caspases (caspase-3 and 7) 
under both normoxic and hypoxic conditions and the caspase activation 
was stronger under hypoxic conditions (D'Alessandro, Basilico et al. 2011). 
These observations are in contrast to the current study as significantly 
lower activation of caspase-3 and inactivation of its substrate PARP in 
comparison to the normoxic conditions was observed. That comes to a 
conclusion that DHA induced antineoplastic effect under both conditions, 
however in normoxia the cells preferentially died by apoptosis while, under 
hypoxic conditions, other mechanism was induced which was caspases 
independent. On the other hand viability assays as WST-1 and trypan Blue 
showed a strong cytotoxic and cytostatic effect under normoxic conditions 
in dose-dependent manner, however, in hypoxic conditions DHA induced 
mostly cytostatic effect and cytotoxicity was observed only at higher DHA 
concentrations in HCT116 wt cells.  
It has been shown from our previous work and from other groups, that 
artemisinin derivatives induce their cytotoxic effect via ROS formation 
(Handrick, Ontikatze et al. 2010; Berdelle, Nikolova et al. 2011; Cabello, 
Lamore et al. 2011). This makes it even more challenging for the studies 
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under hypoxic conditions where artemisinin derivatives could be combined 
with the classical chemotherapy, such as radiotherapy. In this case, 
artemisinin derivative DHA would act as a donor of ROS and improve the 
outcome of therapy in resistant hypoxic tumors. 
4.1.2 DHA induced necrosis in normoxia and hypoxia 
DHA induced not only apoptosis but also necrosis in colon cancer (HC15, 
colo205 and HCT116), Jurkat A3 and in prostate cancer (Du145) cells. 
Interestingly, in normoxia DHA-induced necrosis was increased in Jurkat 
A3 cells when pan-caspase inhibitor zVAD was applied in combination with 
DHA. This indicates that DHA can induce apoptosis independent death 
mode by necrosis. Moreover, DHA induced necrosis in a dose and time 
dependent manner in normoxia, however, it was not further increasing over 
the time in hypoxia according to Hoechst and PI staining in colon cancer 
cells (HC15, colo205 and HCT116). Thus, DHA induced necrosis was 
stronger under normoxic conditions than under hypoxic conditions in 
HCT116 wt.  In contrast to HCT116 wt cells, Colo205 showed only 10 % of 
necrotic cells in response to high DHA concentration (50 µM) and this 
number increased to 50 % at the same DHA concentration in hypoxia. 
Necrosis was significantly increased in HCT15 cells in both normoxia and 
hypoxia in response to high DHA concentrations (25-50 µM). Those results 
revealed that DHA induced apoptosis in both normoxic and hypoxic 
condition, however necrosis is induced with different mode, dependent from 
the cell line. In a similar study on Chinese hamster ovary cell line, necrosis 
induction was shown according to annexin V/PI staining in artesunate 
treated cells at 72 h time point. Necrosis was increasing in a dose 
dependent manner reaching 32 % of necrotic cells in response to 50 µg/ml 
of artesunate (Li, Lam et al. 2008; Berdelle, Nikolova et al. 2011).  
Here, it was for first time shown that DHA could induce necrosis in hypoxia. 
At lower concentrations of DHA (10-25 µM), apoptosis was preferentially 
induced in all the discussed cell lines, however, in response to higher DHA 
concentration (50 µM), death by necrosis was more prominent. This is a 
very interesting result as it shows that DHA can induce alternative death 
pathways in case of apoptosis defective tumor cells.       
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4.1.3 DHA-induced apoptosis and cell cycle arrest is Bax/Bak 
dependent under both, normoxic and hypoxic conditions 
The importance of Bcl-2 family associated to DHA action was studied 
focusing on the pro-apoptotic proteins Bax and Bak. In our previous studies 
on JCAM Bak negative and Bak positive cell lines, it was shown that DHA 
induced caspases activation and apoptosis in Bak dependent manner. DHA 
downregulated the anti-apoptotic protein Mcl-1 and upregulated the pro-
apoptotic protein Noxa in JCAM Bak positive cell line, but not in Bak 
negative cells (Handrick, Ontikatze et al. 2010).  
In the current study, Bax/Bak positive or deficient tumor cells (HCT116 wt, 
Bax negative, Bak negative and Bax/Bak negative as well as Du145 mock 
or Du145 Bax) were used.  Results revealed that DHA was able to induce 
apoptosis in Bax/Bak dependent manner under normoxic and hypoxic 
conditions. In our colon cancer model it was observed that loss of Bax 
could not be substituted in its role in apoptosis induction by Bak, however, 
Bak negative cells could still undergo to a significant induction of apoptosis 
and Bax was sufficient to induce a similar amount of apoptosis as was the 
case in HCT116 wt cells which are Bax and Bak positive. In this model it 
can be concluded that DHA induced apoptosis in HCT116 in Bax 
dependent manner but not Bak, as was shown in JCAM Bak positive cells. 
Bax importance in apoptosis induction was also confirmed from a similar 
study using the same HCT116 model but other chemotherapy (Chandra, 
Choy et al. 2005; Wang and Youle 2011). The importance of Bax could be 
explained in HCT116 cells in consideration of Mcl-1 inhibition of Bak in the 
absence of Bax in response to classical chemotherapy (Gillissen, Wendt et 
al. 2010; Wang and Youle 2011). In this case with the silencing of Mcl-1 
should be possible to induce apoptosis also in Bax absence. Indeed, in a 
recent study the silencing of Mcl-1 by siRNA sensitized Bax negative cells 
to chemotherapy-induced apoptosis according to caspases activation and 
cytochrome-c release. Contemporary, the overexpression of Noxa was also 
sufficient to induce apoptosis in Bax negative cells (Wang and Youle 2011). 
Interestingly, DHA induced Mcl-1 downregulation and Noxa upregulation 
and that was sufficient to activate Bak and induce apoptosis in dose 
dependent manner in JCAM Bak positive cells (Handrick, Ontikatze et al. 
2010). However, DHA did not downregulate Mcl-1 protein levels in HCT116 
wt and HCT116 Bax/Bak negative cells in both normoxic and hypoxic 
conditions (Fig. S1).      
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In Du145 prostate cancer cells, Bax expression significantly supported 
DHA-induced depolarization of the mitochondrial membrane potential and 
DNA fragmentation. In contrast to the Du145 Bax positive cells, Du145 
mock cells, which were only Bak positive but Bax negative, showed no 
depolarization of the mitochondrial membrane potential or DNA 
fragmentation in response to DHA. Taken together these results showed 
that in HCT116 and Du145 model, Bax and not Bak, plays a pivotal role in 
DHA-induced apoptosis. By contrast, loss of Bax in Du145 induced 
significant necrosis in response to DHA. 
Bax activation showed to have a pivotal role for DHA action under both 
normoxia and hypoxia in HCT116 wt cells as it was shown by FACS 
analyses with Bax translocation in the nucleus.    
Under hypoxic conditions, HIF-1 and p53 interact in many ways to finally 
rule for the cell fate. Hypoxia is known to protect cells from apoptosis 
induction in response to classical chemotherapy such as etoposide. It was 
reported that targeting HIF-1 could significantly enhance apoptosis in 
hypoxia (Sermeus, Cosse et al. 2008). In the current study it was shown 
that hypoxia itself did not induce apoptosis in HCT116 model, however, 
DHA induced significant amount of apoptosis with regard to the FACS 
results (Δψm and SubG1) in acute hypoxia 0.2% O2. Worthy of mention, 
apoptosis was strongly downdegulated in absence of Bax. In addition, in 
other colon cancer cells, such as colo205 and HCT15, DHA showed to 
induce both apoptosis and necrosis under both normoxic and hypoxic 
conditions.   
Taking together the data from all the described models, it can be concluded 
that DHA acts in Bax Bak dependent manner (HCT116, Du145 and JCAM), 
but with specific differences dependent on cell type and the 
microenvironment. Bax plays an important role in HCT116 and Du145 
model, leading however to a different apoptosis induction. Du145 cells are 
p53 negative and this could explain the apoptosis decrease in comparison 
to the HCT116 cells which are p53 wt. JCAM Bak positive cells, lacking 
both p53 and Bax, were sensitive to apoptosis induction by DHA. In this last 
model, Bak was sufficient to induce apoptosis in response to DHA via Mcl-1 
downregulation and Noxa upregulation. DHA may preferentially depend 
from Bax or Bak for the apoptosis execution in different cell models 
described.  
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The importance of Bax for apoptosis induction was also described in 
previous studies on treated ovarian cancer cells. In particular, DHA was 
shown to induce an increase in Bax protein level according to the Western 
blots analysis, as well as to the mRNA level measured by RT-PCR, in p53 
independent manner. Loss of Bax by siRNA almost abolished apoptosis 
induction in ovarian cancer cells in normoxia (Jiao, Ge et al. 2007).   This 
favors the data obtained in the current study, in which is shown that DHA 
induced apoptosis is Bax dependent in normoxic conditions. It is necessary 
to mention that it has never been described before that in HCT116 model 
DHA induces apoptosis under nomoxic and, at a lower amount, under 
hypoxic conditions in a Bax dependent manner. 
Focusing on cell cycle distribution in response to DHA, HCT116 wt and 
HCT116 Bax/Bak negative cells were analyzed under normoxic and 
hypoxic conditions. According to the FACS data, DHA induced G2 arrest in 
normoxia and G1 arrest in hypoxia, however in the both cases the 
difference was not significant. On the other hand loss of Bax/Bak did not 
influence the cell cycle distribution in response to DHA in G1 and G2 
phases under both normoxic and hypoxic conditions in comparison to the 
ethanol controls. Interestingly, S phase significantly decreased under 
hypoxic conditions in HCT116 Bax/Bak negative cells.  In similar studies 
from other groups, in ovarian cancer cells and human osteosarcoma cells 
showed significant increase in G2 and decrease in G1 phase in normoxic 
conditions (Jiao, Ge et al. 2007; Ji, Zhang et al. 2011). On the other hand 
DHA induced cell cycle arrest in G1 phase in HCT116 colon cancer cells 
and pancreatic cancer BxPC- cells  in normoxia (Chen, Sun et al. 2010; Lu, 
Chen et al. 2011). In addition, DHA induced G2 arrest in immortalized 
human microvascular endothelial HMEC-1 cells at dose (12.5 -50 µM DHA) 
in both normoxic and hypoxic conditions (D'Alessandro, Basilico et al. 
2011). Those results show that DHA-induced cell cycle arrest depending on 
cell type. These inconsistencies are probably due to metabolic features of 
the cells leading to different growth rates. The G2 cell cycle arrest could be 
caused by DNA damage (Li, Lam et al. 2008).   
It has been reported that DHA exerts cytotoxic effects by inhibiting the 
hypoxia inducible factor and its targets, such as VEGF.  DHA exerted 
selectively on glioma C6 cells by increasing the reactive oxygen species 
and inhibited hypoxia inducible factor HIF-1  
dose and time dependent manner (Huang, Ma et al. 2007) Here was 
 4 Discussion 
 
 82 
examined HIF-1α expression at the protein level in HCT116 wt, HCT116 
Bak -/-, HCT116 Bax -/- and HCT116 Bax/Bak -/- over the time (2 h-24 h 
Hypoxia).    
Results revealed that HIF-1α expression started to be detectable at 2 h 
time point and it was increased over the time until 12 h and decreased at 
24 h time point in all the cell lines. In addition, from preliminary data, DHA 
influences the protein level of HIF-1α in Bax/Bak dependent manner. 
HCT116 wt cells showed no differences in HIF-1α expression in response 
to DHA treatment. Interestingly, HCT116 Bak -/-, HCT116 Bax -/- and 
HCT116 Bax/Bak -/- showed decrease in HIF-1α levels to half in DHA 
treated cells in comparison to the ethanol controls at 12 h time point. In 
conclusion DHA induced downregulation of HIF-1α and it was even 
stronger in Bax/Bak absence. That is an important observation because 
HIF-1 correlates with poor prognosis in classical chemotherapy (Unruh, 
Ressel et al. 2003; Brown, Cowen et al. 2006; Sullivan, Pare et al. 2008). 
4.1.4 DHA induces increase in autophagy  
In contrast to the short term experiments, long term experiments, such as 
colony formation assay, showed that, DHA induced clonogenic death in 
HCT116 cells independently of Bax or Bak presence under hypoxic 
conditions indicating for the alternative mechanism which is taking place in 
DHA-induced death.   
Investigating the alternative pathways that could contribute to the Bax and 
Bak independent cytotoxic effect of DHA, autophagy was promising 
mechanisms of DHA-induced death. Based on data from 
immunofluorescence and western blots analyses, for the first time it was 
shown that DHA induced autophagy in HCT116 wt and HCT116 Bax/Bak 
deficient cells and autophagy was strongly increased under hypoxic 
conditions in HCT116 Bax/Bak negative cells. This may suggest an 
alternative mechanism involved in DHA induced Bax/Bak independent 
clonogenic death.  
From studies in Jurkat A3 cells, in which anti-apoptotic proteins such as 
Bcl-2 were overexpressing, Helanin, a sesquiterpene lactone, could bypass 
Bcl-2 mediated cell death resistance. ROS formation was required for cell 
death and the key factor found to be involved in Bcl-2 overexpressed Jurkat 
cells death was the Nf-kB inhibition. In contrast to the current study, they 
could not observe autophagy induction (Hoffmann, von Schwarzenberg et 
al. 2011). Here was also shown that DHA induced autophagy not in all cell 
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models. In prostate cancer Du145 mock and Bax positive DHA treatment 
showed no autophagy induction. This could be explained because Du145 
cells are p53 negative and p53 plays an important role in positive regulation 
of autophagy by activating specific targets such as DRAM family (D'Amelio 
and Cecconi 2009; Maiuri, Malik et al. 2009; Ryan 2011). From another 
study, deficiency of apoptotic effectors Bax and Bak, showed to induce 
autophagic cell death pathway in response to chemotherapy  (Dolmans, 
Fukumura et al. 2003).   
Most of the studies on artemisinin derivatives have been done in normoxia. 
However, little is known about their action in hypoxia. The present study 
introduces new explanations of DHA action under hypoxic conditions. It 
may be that DHA acts through autophagy induction in response to Bax/Bak 
absence in HCT116 model and, in case of prostate cancer cells which are 
not undergoing autophagy, DHA treatment induces an increase in necrosis 
in Bax absence. The other important observation is that DHA is able to 
induce apoptosis and necrosis in normoxia and hypoxia in p53 independent 
manner as shown from results in HCT15 (p53 mutated cells) and colo205 
with p53 wt. In addition, DHA induced a small amount of apoptosis also in 
Bax/Bak negative cells, thus suggesting that DHA can induce apoptosis by 
activation of alternative apoptotic pathway, independently from the intrinsic 
apoptotic pathway. Finally, DHA decreased HIF-1α protein levels which 
suggests further contribution in the antineoplastic efficacy of clonogenic 
Bax/Bak deficient tumor cells. 
4.2 DHA in combination treatments 
The second aim of this work was to study whether DHA acts as a sensitizer 
to ionizing radiation treatment in normoxia and hypoxia in HCT116 wt cells. 
Several studies have been done using the artemisinin derivative in 
combination treatments with Gemsitabine (Hou, Wang et al. 2008), TRAIL 
antibodies (Handrick, Ontikatze et al. 2010), ionizing radiation (Kim, Kim et 
al. 2006) and other chemotherapeutics (Zhou, Zhang et al. 2010). In all 
those studies was shown that artemisinin derivatives acted as sensitizers to 
chemotherapy.   
In the current study, it was first investigated whether apoptosis induction 
was increased in combination treatments in HCT116 wt cells. It was 
observed by FACS and Western blot analyses that DHA did not additionally 
contribute in apoptosis induction in combination treatments in comparison 
to the single treatments under both normoxic and hypoxic conditions. In 
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JCAM Bak positive cells it has been shown that DHA synergistically 
induced apoptosis in combination with radiation treatment (Handrick, 
Ontikatze et al. 2010), suggesting different responses in different tumor 
models.  
As it was previously described, DHA produces reactive oxygen species 
(Berman and Adams 1997; Handrick, Ontikatze et al. 2010) and it is 
essential for its cytotoxic effect. ROS importance in autophagy induction 
was studied by Jae-Min Yuk and collaborators. They focused on 
chemotherapy of colon cancer with cell wall skeleton of mycobacterium 
bivis Bacillus Calmette-Guerin (BCG/CWS). They found that when it was 
applied in combination with ionizing radiation in colon cancer treatment 
resulted in the induction of caspase independent death by autophagy. This 
result was achieved by the generation of ROS (Yuk, Shin et al. 2010). This 
work suggests that generation of ROS could lead to a cell death by 
autophagy. It could give a hint that ROS formations could sensitize the cells 
to ionizing radiation by inducing autophagic death. Indeed, DHA showed 
additive effect on the induction of autophagy in comparison to the single 
treatments with even stronger effect in hypoxia. The results showed that 
DHA differentially acts as a sensitizer to ionizing radiation depending on the 
tumor model.  
Focusing further on the mechanism of DHA action in combination with 
ionizing radiation, results revealed that DNA double strands breaks were 
not efficiently repaired over the time (in comparison to the only irradiated 
cells) until the time point 4 h. In contrast to Berdelle et al. , DHA did not 
induce DSBs in comparison to the ethanol control and was not altered over 
the time. In parallel to this experiment, immunofluorescence was performed 
with the same conditions and this allowed showing that in combination 
treatment there was a significant increase in number of DNA double strand 
breaks already at the early time point (30 minutes) and these were 
significantly higher than in cells treated only with radiation. DBSs were 
reduced in number until 4 h time point and after were increased again. 
Those differences in number of DBSs/cell could be explained as artemisinin 
derivatives were reported to induce oxidative stress according to the 8-
oxoG and EthenoA markers. It was shown that artesunate (15 µg/ml) 
induced a significant increase of DNA double strand breaks over the time 
differently when compared to ionizing radiation (Berdelle, Nikolova et al. 
2011). That could suggest that due to accumulations of the oxidative 
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damage from the drug could lead to persistence of DNA damage over the 
time when it is combined with ionizing radiation. In the current study it is 
shown for the first time that DHA in combination treatment with radiation 
lead to the accumulation of DNA damage and finally led to clonogenic 
death in colon cancer cells (HCT116 wt). Here DHA showed to be a 
sensitizer of the cells to the radiation-induced death by suspected 
accumulation of DNA damage that lead to death. Long term experiments, 
as colony formation assay, convinced that DHA induced clonogenic death 
when used in combination with ionizing radiation in comparison to the 
single treatments. Similar observations have been done on U273MG 
glioma cells, in which DHA in combination with ionizing radiation enhanced 
the radiosensitizing effect and was highly dependent from ROS formation 
(Kim, Kim et al. 2006). The analyzing of the shape and structure of the 
colonies under the microscope helped to reveal that, when treated with 
ionizing radiation alone or in combination with DHA, the cells were showing 
a giant phenotype. The giant cells were suspected to be senescent; 
however, the cells showed negative staining for senescence (Fig. S2).  
In addition from the colony formation assays, it was shown that when DHA 
was all the time present into the media of the cells, showed to be more 
toxic to the cells and it was leading to eradication of HCT116 wt cells. 
However, in case of delayed plating there DHA was only 24 h present and 
then replaced with fresh medium drug free, the cells were able to enter 
again the mitosis and recover with almost no eradication of the tumor cells. 
The differences between direct and delayed plating could be explained as 
in case of direct plating, it gives primary cytostatic effect from the drug as 
well as cytotoxic effect. In case of delayed plating it gives the information 
about the first kill (as long as the drug is present). From current study it 
comes clear that in single treatments with only DHA, the drug should be 
present in order to induce its cytotoxic effect for all the time period of the 
experiment. In contrast to current study, similar study on artesunate where 
the replacement of the drug by fresh medium showed to lead to higher 
apoptosis induction if the drug would be all the time present during the 
experiment (Liu, Gravett et al. 2011).  On the other hand in single treatment 
with irradiation or in combination treatments showed to induce a significant 
eradication of the tumor cells using the delayed plating method. That 
suggests that DHA sensitizes tumor cells to ionizing radiation at early time 
point.  
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From the preliminary in vivo studies on human HCT116 xenograft model, it 
was shown that DHA in combination with ionizing radiation induced tumor 
growth delay in comparison to the controls or to the single treatments (Fig. 
S3) (Ontikatze, Henke et al. unpublished data). Similar results were 
obtained on human non-small cell lung cancer cells A549 applying 
combination treatments with artesunate and ionizing radiation (Zhao, Jiang 
et al. 2011). However, a stronger delay on tumor growth could not be seen 
when artesunate was applied instead of DHA in combination treatments in 
comparison to radiation alone (data not shown). 
In summary, DHA enhanced the radiosensitivity of HCT116 colon cancer 
cells via accumulation of oxidative stress and DNA damage and possibly 
autophagy induction. It is hypothesized that ROS formation derived from 
DHA treatment could induce oxidative stress and DNA damage and thus, 
could help ionizing radiation to induce its cytotoxic effect.      
  
4.3 Clinical relevance 
As it was described in the introduction, artemisinin derivatives are widely 
used as anti malaria treatment in populations with high malaria incidence. 
The drug showed no side effects at concentrations in the nanomolar range. 
In addition, the drug showed selective toxicity to the parasites infected 
erythrocytes (Klayman 1985). Recently artemisinin derivatives showed to 
exert antineoplastic effects in cancer therapy in vitro and in vivo (Efferth, 
Dunstan et al. 2001; Dell'Eva, Pfeffer et al. 2004; Efferth 2005). 
Interestingly, in all the studies artemisinin derivatives showed selective 
activity only on tumor cells and were not affecting normal cells (Hou, Wang 
et al. 2008). This depends on the bio-activation of the drug, which requires 
iron, making the drug selectively active only on cells with high iron uptake. 
Highly proliferative cancer cells need high iron uptake and it has been 
reported that, in contrast to the normal cells, tumor cells express higher 
levels of transferrin receptor (Lai, Sasaki et al. 2005). In addition, a clinical 
case report on two patients with metastatic uveal melanoma presented 
preliminary evidence in support of the potential therapeutic benefit 
associated with artesunate chemotherapy (Berger, Dieckmann et al. 2005). 
The described observations make the artemisinin derivatives a good 
candidate for the tumor treatments with no side effects. 
It is important to establish treatments that could sensitize solid tumor to 
classical chemotherapy and radiotherapy, considering that hypoxia is a 
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common phenomenon in solid tumors. In severe or prolonged hypoxia, 
tumor cells usually adapt to the environmental stress and escape apoptosis 
and necrosis during classical chemotherapy (Hickman, Potten et al. 1994). 
Here it was proposed to use ROS-donors, such as DHA, which showed to 
have an antineoplastic effect in acute hypoxia (0.2 % O2) and, moreover, it 
was able to sensitize tumor cells to ionizing radiation apoptosis and 
autophagy induction. Therefore, DHA is a promising candidate in hypoxic 
tumor therapy and in combination therapies with ionizing radiation. 
4.4 Proposed mechanism of DHA action under normoxic and 
hypoxic conditions 
It is hypothesized that DHA-induced apoptosis is duo to ROS formation 
which is upstream of the mitochondria. It was shown from our previous 
work on Jurkat E6.1 cells that ROS scavengers, such as N-acetylcysteine 
or glutathione, were efficient to decrease significantly the ROS formation 
and, subsequently, to decrease apoptosis significantly induction (Handrick, 
Ontikatze et al. 2010). The observation that ROS formation is required to 
induce apoptosis, making it even more interesting in hypoxia where ROS 
production would offer molecular oxygen and would help DHA to induce 
apoptosis under hypoxic conditions.  
DHA-induced apoptosis was shown to be Bax dependent. Bax importance 
was concluded from Bax Bak positive HCT116 cells and Bax or Bak 
deficient cells. Loss of Bax had a significant abrogation in apoptosis 
induction and Bak was not able to substitute Bax in HCT116 model. When 
used on JCAM Bak positive T-Lymphoma cells, DHA showed to induce Bak 
dependent apoptosis via Mcl-1 downregualation and Noxa upregulation. 
Those results come to suggest that DHA induce apoptosis in Bax/Bak 
dependent manner depending from the cell type.  
Another mechanism of death induced by DHA was necrosis. Necrosis was 
induced in all the described cell models. However, the exact mechanism 
behind DHA-induced necrosis is still not known. Interestingly, necrosis was 
enhanced when caspases were blocked by zVAD in Jurkat model and at 
higher DHA concentration (Fig. 46).  
Finally, here was proposed autophagic death mode which was induced as 
an alternative death pathway in apoptosis deficient cells. DHA induced 
autophagy in HCT116 wt and HCT116 Bax/Bak negative cells and it was 
even higher under hypoxic conditions. Persistence of autophagy may 
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contribute to clonogenic death in Bax/Bak independent manner under 
hypoxic conditions. 
In combination treatments with ionizing radiation, ROS formation induced 
significant apoptosis; however, apoptosis was not increased compared to 
single treatment with DHA under both normoxic and hypoxic condition. In 
addition, it was shown that in combination treatments autophagy was highly 
increased and showed additive effect under both normoxic and hypoxic 
conditions (Fig. 47). Interestingly, ROS formation induced persistence of 
DNA double strand breaks (DSBs) in combination treatments, however, 
DHA alone did not induce DSBs. 
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Fig. 46 Suggested mechanism of DHA action in HCT116 model. DHA induces 
apoptosis in a Bax/Bak dependent manner in HCT116 cells under normoxic and 
hypoxic conditions. Apoptosis is the most prominent death mode under normoxic 
conditions. In Bax/Bak deficient cells DHA induces autophagy, particularly under 
hypoxia. Therefore, It suggests that DHA induces autophagic death as an 
alternative death mode under hypoxic conditions and this may contribute to 
clonogenic death in Bax/Bak deficient cells. 
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Fig. 47 Suggested mechanism in combination treatments in HCT116 model.  
The combination treatment of DHA with ionizing radiation showed increased 
autophagy under both normoxic and hypoxic conditions. In addition significant 
apoptosis was induced however it was not higher than DHA-induced apoptosis 
alone. Here, it is proposed that DHA-induced autophagy leads to XRT-induced 
clonogenic death in combination treatments.   
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5 Summary 
The microenvironment of solid tumors is mostly characterized by regions of 
acute and chronic hypoxia which are known to decrease sensitivity of tumor 
cell to classical chemotherapy and radiotherapy. Here is proposed a novel 
strategy to overcome therapy resistance of solid tumor cells under acute 
hypoxia and to increase the efficacy of radiotherapy by using the radical-
forming endoperoxide Dihydroartemisinin (DHA) that is known as anti-
malaria drug and has only recently been shown to have antineoplastic 
activity. Aim of the current study was to evaluate the antineoplastic activity 
of DHA under normoxic and hypoxic conditions, to elucidate the importance 
of the intrinsic apoptotic pathway for drug activity in both conditions, and to 
study its potential to improve the cytotoxic action of ionizing radiation. 
The cytotoxic effects of DHA (0-80 µM) were evaluated in colon cancer 
cells (HCT15, Colo205 and HCT116) and Jurkat T-lymphoma cells using 
short term (apoptosis, necrosis, autophagy and viability assays) and long 
term assays (colony formation). HCT116 cells with or without expression of 
Bax, Bak, or both were used to study the importance of the intrinsic 
apoptotic pathway for efficacy of DHA in normoxia and hypoxia. For 
combined treatment, ionizing radiation (0-10 Gy) was applied 10 minutes 
after DHA treatment.  
In normoxia, DHA efficiently induced concentration- and time-dependent 
apoptosis in Jurkat and colon cancer cells. The cells were also sensitive to 
DHA-induced apoptosis in hypoxia. Loss of proapoptotic Bax, Bak, or both 
largely decreased DHA-induced apoptosis in normoxia and hypoxia. 
Although loss of Bax, Bak or both impaired DHA-induced eradication of 
clonogenic tumor cells in normoxia, clonogenic cell death was almost not 
affected by loss of those proapoptotic proteins in hypoxia suggesting 
alternative death mechanisms. Autophagy was identified as an alternative 
cellular response in hypoxia. Cell death from autophagy may at least 
partially compensate for apoptosis deficiency in cells with defects of the 
intrinsic apoptosis pathway and may also contribute to the increased 
efficacy of radiotherapy in combination with DHA. Combination treatment 
with XRT increased clonogenic death in Bax/Bak positive HCT116 cells in 
normoxia and enhanced the persistence of γ-H2AX foci suggesting an 
impact of DHA on the repair of DNA double strands breaks or the 
accumulation of DNA damage by DHA-triggered oxidative stress.  
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All together findings of the current work suggest that DHA may be a good 
candidate for the treatment of hypoxic human tumors characterized by 
apoptosis resistance and for combined treatment with ionizing radiation. 
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7.1 Supplementary data  
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Fig. S1: Mcl-1 is not influenced by DHA treatment in HCT116 wt, but it is 
upregulated in response to loss of Bax/Bak.  HCT116 wt and HCT16 duo Bax/Bak 
negative cells were plated and treated under normoxic or hypoxic conditions. At the 8 h 
time point, cells were lysed for the Western blots. Tubulin was used as the loading control 
and it was considered in the densitometric analysis. The experiment was performed two 
times and the representative blots are shown.    
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Fig. S2: DHA-induced senescence is Bax/Bak independent. HCT116 wt and 
Duo Bax/Bak negative cells were plated and treated with DHA under normoxic and 
hypoxic conditions. The cells were stained for senescence after 6 and 8 days of 
DHA treatment. In case of hypoxia the cells were incubated for 24 h at 0.2 % O2 
and then under normoxic conditions. Scale bar corresponds to 100 μΜ. The 
experiment was done only one time.  
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Fig. S3: DHA in combination with ionizing radiation induced delay in HCT116 
tumor growth in vivo. Human HCT116 cells were implanted to the leg of nude 
mice (xenograft model). When the tumors reached 100 cm
3
, animals were treated 
with 100mg/kg DHA or 2 Gy or the combination of both. Treatments took place for 
5 days. In case of combination treatments, DHA was injected intraperitoneally half 
an hour before the ionizing radiation. In control mice, DMSO was injected (DHA 
was solved in DMSO). Tumor volume was measured two times a week and the 
experiments stopped when the tumor reached 8 fold the initial volume. The graph 
represents one single experiment and data from 5 mice per group.      
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7.2 Abbrevations 
 
A 
ADP 
AIF 
APAF1 
APS 
ART 
Atg 
ATM 
ATP 
ATR 
 
B 
Bad 
Bak 
Bax 
Bcl-2 
Bcl-xL 
BH 
Bid 
Bim 
BSA 
 
C 
CARD 
CBP 
CCCP 
CD95R 
CD71 
Cy2 
 
 
D 
DISK 
DMSO 
DNA 
DNA-PKc 
DD 
DED 
DHA 
DSBs 
DTT 
∆ψm 
 
E 
ECL 
EDTA 
ELISA 
ER 
EtOH 
 
 
 
 
Adenosinediphosphate 
Apoptosis inducible factor 
Apoptotic protease activating factor 1 
Ammonium persulfate  
Artemisinin  
AuTophaGy related 
Ataxia telangiectasia mutated 
Adenosin-Tri-Phosphat 
ATM and Rad3-related 
 
 
Bcl-xL/Bcl-2 associated death promotor 
Bcl-2 antagonist / killer 
Bcl-associated X-protein 
B-cell lymphoma 2 
B-cell lymphoma-extra large 
Bcl-2 homology domain 
Bcl-2 interacting domain 
Bcl-2 interacting mediator of cell death 
Bovine serum albumin 
 
 
Caspase recruitment domain 
CREB Binding Protein 
Protonophore carbonyl cyanide m-chlorophenylhydrazone 
CD95 receptor  
Transferrin reseptor  
Cyanine Dye 2 
 
 
 
Death inducing signaling complex 
Dimethylsulfoxid 
Deoxyribonucleic acid 
DNA-dependent protein kinase, catalytic subunit 
Death domain 
Death effector domain 
Dihydroartemisinin  
DNA double strand breaks 
Dithiothreitol 
Mitochondrial Membrane Potential 
 
 
Enhanced-chemiluminescence 
Ethylen-Diamin-Tetraacetat 
Enzyme-linkedimmunosorbentassay 
Endoplasmic reticulum 
Ethanol 
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F 
FACS 
FADD 
FDR 
FBS 
Fig. 
FITC 
FSC 
 
G 
GF 
GFP 
 
H 
HEPES 
HIF-1 
H2AX 
HCL 
HRP 
HREs 
Hx 
 
I 
IgG 
 
K 
KCl 
 
 
L 
LC3 
 
 
M 
Mcl-1 
mTOR 
MgCl2 
 
 
N 
NaCl 
NADPH 
NaOH 
NF-κB 
Neg 
NT 
Nx 
 
O 
OD 
2-OG 
 
P 
PARP 
PE 
PI3k 
 
Fluorescence Activated Cell Sorting 
Fas-Associated protein with Death Domain 
Fractions of DNA released 
Fetal Bovine Serum  
Figure  
Fluorescein Isothiocyanat 
Forward-scattered  
 
 
Growth Factor  
Green fluorescent protein 
 
 
N-(2-Hydroxyethyl)-Piperazin-N’-2-Ethansulfonsäure 
Hypoxia-inducible factor 1 
H2A histone family, member X 
Hydrogen chloride 
Horseradish peroxidase 
hypoxia-response elements 
Hypoxia 
 
 
Immunglobulin G 
 
 
Potassium chloride 
 
 
 
Light chain 3 
 
 
 
Myeloid cell leukemia sequence 1 
Mammalian target of rapamycin 
Magnesium chloride 
 
 
 
Natriumchlorid 
Nicotinamide adenine dinucleotide phosphate-oxidase 
Sodium hydroxide 
Nuclearfactor-kappa B 
Negative 
N-terminal 
Normoxia 
 
 
Optical density 
2-oxoglutarate 
 
 
Poly (ADP-ribose) polymerase 
Plating efficiency  
Phosphoinositid-3-Kinasen 
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p53 
PBS 
PFA 
PFGE 
PHD 
PI 
PIKKs 
PKB 
PTEN 
PVDF 
pVHL 
 
R 
RNA 
ROS 
rpm 
RPMI 
RT 
 
S 
SD 
SDS 
SF 
SSC 
 
T 
TBE 
TBS 
TEMED 
TMRE 
TNF 
TRAIL 
Tris 
Tween-20 
 
 
V 
pVHL 
VEGF 
 
W 
WST-1 
Wt 
 
X 
X-gal 
XRT 
 
Z 
zVADfmk 
 
 
protein 53 
Phosphat-buffered Saline 
Paraformaldehyde 
Pulsed-field gel electrophoresis 
Proline hydroxylases 
Propidium Iodide  
Phosphatidylinositol 3-kinase-related kinases 
protein kinase B 
Phosphatase and Tensin homolog 
Polyvinylidene fluoride 
Product of the von Hippel–Lindau 
 
 
Ribo nucleic acid 
Reactive oxygen species  
Rounds per minute 
Roswell Park Memorial Institute Medium 1640 
Room temperature 
 
 
Standard deviation   
Sodium dodecyl sulfate 
Survival fraction  
Side-scattered 
 
 
Tris base, boric acid and EDTA 
Tris Buffered Saline 
N, N’, N’–tetramethylethylendiamine 
Tetramethylrhodaminethylester-perchlorate  
Tumor necrosis factor 
TNF-related apoptosis-inducing ligand 
Tris-(hydroxymethyl)-aminomethane 
Polyoxyethylen-(20)-sorbitanmonolaurat 
 
 
 
von Hippel-Lindau 
Vascular endothelial growth factor 
 
 
Stable tetrazolium salt 
Wild type 
 
 
5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside 
Radiation Therapy 
 
 
Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- fluoromethylketone 
  
 
Für Mengen-, Größen-, Zeit- oder andere physikalische Angaben wurden SI-
(Internationales Einheitensystem) oder gesetzliche Einheiten gewählt. 
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